Shareholders with losses of $50,000 or more are encouraged to contact the firm.
, /PRNewswire/ -- The Law Offices of Howard G. Smith announces that investors with substantial losses have opportunity to lead the securities fraud class action lawsuit against Oracle Corporation ("Oracle" or the "Company") (NYSE: ORCL).
IF YOU ARE AN INVESTOR WHO SUFFERED A LOSS IN ORACLE CORPORATION (ORCL), CONTACT THE LAW OFFICES OF HOWARD G. SMITH BEFORE APRIL 6, 2026 (LEAD PLAINTIFF DEADLINE) TO PARTICIPATE IN THE ONGOING SECURITIES FRAUD LAWSUIT.
Contact the Law Offices of Howard G. Smith to discuss your legal rights by email at [email protected], by telephone at (215) 638-4847 or visit our website at www.howardsmithlaw.com.
What Is The Lawsuit About?
The complaint filed alleges that, between June 12, 2025 and December 16, 2025, Defendants failed to disclose to investors that: (1) Oracle's AI infrastructure strategy would result in massive increases in CapEx without equivalent, near-term growth in revenue; (2) the Company's substantially increased spending created serious risks involving Oracle's debt and credit rating, free cash flow, and ability to fund its projects, among other concerns; and (3) as a result, Defendants' positive statements about the Company's business, operations, and prospects were materially misleading and/or lacked a reasonable basis at all relevant times.
Contact Us To Participate or Learn More:
If you wish to learn more about this class action, or if you have any questions concerning this announcement or your rights or interests with respect to the pending class action lawsuit, please contact:
Howard G. Smith, Esq.,
Law Offices of Howard G. Smith,
3070 Bristol Pike, Suite 112,
Bensalem, Pennsylvania 19020,
Call us at: (215) 638-4847
Email us at: [email protected],
Visit our website at: www.howardsmithlaw.com.
To be a member of the class action you need not take any action at this time; you may retain counsel of your choice or take no action and remain an absent member of the class action.
This press release may be considered Attorney Advertising in some jurisdictions under the applicable law and ethical rules.
Contact Us:
Law Offices of Howard G. Smith
Howard G. Smith, Esquire
215-638-4847
[email protected]
www.howardsmithlaw.com
SOURCE Law Offices of Howard G. Smith
2026-03-05 17:056d ago
2026-03-05 12:006d ago
Navan, Inc. (NAVN) Shareholders Who Lost Money Have Opportunity to Lead Securities Fraud Lawsuit
, /PRNewswire/ -- The Law Offices of Howard G. Smith announces that investors with substantial losses have opportunity to lead the securities fraud class action lawsuit against Navan, Inc. ("Navan" or the "Company") (NASDAQ: NAVN).
IF YOU ARE AN INVESTOR WHO SUFFERED A LOSS IN NAVAN, INC. (NAVN), CONTACT THE LAW OFFICES OF HOWARD G. SMITH BEFORE APRIL 24, 2026 (LEAD PLAINTIFF DEADLINE) TO PARTICIPATE IN THE ONGOING SECURITIES FRAUD LAWSUIT.
Contact the Law Offices of Howard G. Smith to discuss your legal rights by email at [email protected], by telephone at (215) 638-4847 or visit our website at www.howardsmithlaw.com.
What Is The Lawsuit About?
The complaint filed alleges that, pursuant and/or traceable to the Registration Statement issued in connection with the Company's October 31, 2025 initial public offering ("IPO"), Defendants failed to disclose to investors that: (1) at the time of the IPO, the Company had increased its "sales and marketing" expenses by 39% for the quarter ending October 31, 2025 ($95 million) to sustain its revenue, Gross Booking Volume, and usage yield growth; and (2) as a result, Defendants' positive statements about the Company's business, operations, and prospects were materially misleading and/or lacked a reasonable basis at all relevant times.
Contact Us To Participate or Learn More:
If you wish to learn more about this class action, or if you have any questions concerning this announcement or your rights or interests with respect to the pending class action lawsuit, please contact:
Howard G. Smith, Esq.,
Law Offices of Howard G. Smith,
3070 Bristol Pike, Suite 112,
Bensalem, Pennsylvania 19020,
Call us at: (215) 638-4847
Email us at: [email protected],
Visit our website at: www.howardsmithlaw.com.
To be a member of the class action you need not take any action at this time; you may retain counsel of your choice or take no action and remain an absent member of the class action.
This press release may be considered Attorney Advertising in some jurisdictions under the applicable law and ethical rules.
Contact Us:
Law Offices of Howard G. Smith
Howard G. Smith, Esquire
215-638-4847
[email protected]
www.howardsmithlaw.com
SOURCE Law Offices of Howard G. Smith
2026-03-05 17:056d ago
2026-03-05 12:006d ago
10,000 U.S. Storms Turn Severe Each Year -- Mercury Insurance Urges Pre-Storm Action
With 5,000 hail events and peak tornado months ahead, families urged to act now
, /PRNewswire/ -- The United States experiences roughly 100,000 thunderstorms each year — and about 10% escalate into severe storms capable of producing damaging hail, tornadoes and destructive wind. As peak tornado and hail season approaches, Mercury Insurance (NYSE/NYSE Texas: MCY) is urging homeowners and drivers to take preventive steps before the most volatile weather arrives.
Spring is peak season for severe thunderstorms, especially in Texas and Oklahoma, where tornado activity ramps up from April through June.
Texas led the nation in preliminary tornado reports in 2025 with 162 twisters, followed closely by Illinois with nearly 150 — a clear reminder of how frequently severe storms threaten homes and vehicles.
Damage can escalate quickly. A single tornado near Houston in November 2025 damaged more than 100 homes.
Risk isn't limited to the Plains. Georgia typically peaks from March through May, Illinois from April through June, and in the Northeast, New York and New Jersey see their highest tornado activity from June through August — extending the severe weather season well beyond spring.
"Severe weather can create significant damage in a matter of minutes, which is why preparation ahead of the season matters," said Steve Bennett, Head of Climate and Catastrophe Science at Mercury Insurance. "Reducing that risk often comes down to a few practical steps taken early — protecting vulnerable property, paying attention to forecasts, and understanding coverage before severe weather arrives."
Regional Risk: Where Severe Weather Hits Hardest
Texas & Central Plains: Hail Alley
Large hail can damage roofs, siding, solar panels and vehicles in minutes. Texas consistently leads the country in hail-related insurance claims.
Prepare by:
Parking vehicles under cover when severe weather is forecast Inspecting roofing materials and sealing vulnerable areas Trimming trees and securing loose outdoor property Midwest & Southeast: Tornadoes and Destructive Winds
High-wind events and tornadoes can cause structural roof failure, downed power lines and widespread debris damage.
Prepare by:
Reinforcing garage doors Securing patio furniture and outdoor equipment when severe weather is forecast Reviewing wind coverage limits in homeowners policies California: Atmospheric Rivers and Flood Risk
California's severe weather looks different from the tornado and hail threats common in Texas and the Plains. Much of the state's weather-related property risk is tied to atmospheric rivers during the cooler months, when heavy rain can drive flooding, runoff and debris flows — especially in and below wildfire burn scars. On average, about 75% of California's annual precipitation falls from November through March.
Prepare by:
Clearing gutters and storm drains Moving vehicles to higher ground during flood watches Evaluating separate flood insurance coverage, as standard homeowners policies do not cover flood damage Vehicles at Elevated Risk During Spring Storms
Hail, falling debris and flash flooding are leading drivers of spring auto claims. Comprehensive coverage typically protects against these perils. "Vehicles are often exposed during fast-moving storm systems," Bennett said. "Covered parking, paying attention to weather alerts and understanding your coverage can significantly reduce both disruption and out-of-pocket costs." Why Acting Before the Storm Matters
Severe storm losses have steadily increased due to expanding development in high-risk areas and rising material and labor costs. Proactive maintenance and risk awareness can help:
Reduce claim severity Prevent secondary water intrusion damage Shorten recovery timelines "Insurance helps families recover," Bennett added. "But resilience begins before the first weather warning."
For storm preparation resources and coverage guidance, visit the Mercury Blog.
About Mercury Insurance
Mercury Insurance (NYSE: MCY) is a multiple-line insurance carrier predominantly offering personal auto, homeowners, renters and commercial insurance through a network of independent agents in Arizona, California, Georgia, Illinois, Nevada, New Jersey, New York, Oklahoma, Texas and Virginia, as well as auto insurance in Florida. Mercury writes other lines of insurance in various states, including commercial, business owners and business auto, landlord, home-sharing, ride-hailing and mechanical protection insurance.
Since 1962, Mercury has provided customers with tremendous value for their insurance dollar by pairing ultra-competitive rates with excellent customer service, through more than 4,200 employees and a network of more than 6,340 independent agents in 11 states. Mercury has earned an "A" rating from A.M. Best, as well as "Best Auto Insurance Company" designations from Forbes and Insure.com. For more information visit www.MercuryInsurance.com or follow the company on X, Instagram or Facebook.
Media interested in receiving updates from Mercury can learn more at the Mercury Newsroom.
SOURCE Mercury Insurance
2026-03-05 17:056d ago
2026-03-05 12:006d ago
Bronstein, Gewirtz & Grossman LLC Urges NuScale Power Corporation Investors to Act: Class Action Filed Alleging Investor Harm
NEW YORK, March 05, 2026 (GLOBE NEWSWIRE) -- Bronstein, Gewirtz & Grossman, LLC, a nationally recognized investor-rights law firm, announces that a class action lawsuit has been filed against NuScale Power Corporation (NYSE: SMR) and certain of its officers.
This lawsuit seeks to recover damages against Defendants for alleged violations of the federal securities laws on behalf of all persons and entities that purchased or otherwise acquired NuScale securities between May 13, 2025 and November 10, 2025, both dates inclusive (the “Class Period”). Such investors are encouraged to join this case by visiting the firm’s site: bgandg.com/SMR.
NuScale Case Details
The Complaint alleges that the defendants throughout the Class Period made false and/or misleading statements and/or failed to disclose that:
(1) ENTRA1 had never built, financed, or operated any significant projects – let alone projects in the highly technical and complicated field of nuclear power generation – during its entire operating history;
(2) NuScale had entrusted its commercialization, distribution, and deployment of its NPMs and hundreds of millions of dollars of NuScale capital to an entity that lacked any significant prior experience owning, financing, or operating nuclear energy generation facilities;
(3) the purported experience and qualifications attributed to ENTRA1 by defendants during the Class Period in fact referred to the purported experience and qualifications of the principals of the Habboush Group, a distinct entity without significant experience in the field of nuclear power generation; and
(4) as a result, NuScale’s commercialization strategy was exposed to material, undisclosed risks of failure, delays, regulatory challenges, or other negative setbacks.
What's Next for NuScale Investors?
A class action lawsuit has already been filed. If you wish to review a copy of the Complaint, you can visit the firm’s site: bgandg.com/SMR. or you may contact Peretz Bronstein, Esq. or his Client Relations Manager, Nathan Miller, of Bronstein, Gewirtz & Grossman, LLC at 917-590-0911. If you suffered a loss in NuScale you have until April 20, 2026, to request that the Court appoint you as lead plaintiff. Your ability to share in any recovery doesn't require that you serve as lead plaintiff.
No Cost to NuScale Investors
We, Bronstein, Gewirtz & Grossman LLC, represent investors in class actions on a contingency fee basis. That means we will ask the court to reimburse us for out-of-pocket expenses and attorneys’ fees, usually a percentage of the total recovery, only if we are successful.
Why Bronstein, Gewirtz & Grossman, LLC for NuScale Securities Class Action?
Bronstein, Gewirtz & Grossman, LLC is a nationally recognized firm that represents investors in securities fraud class actions and shareholder derivative suits. Our firm has recovered hundreds of millions of dollars for investors nationwide. More at www.bgandg.com
"Our practice centers on restoring investor capital and ensuring corporate accountability, which serves to uphold the essential integrity of the marketplace," said Peretz Bronstein, Founding Partner of Bronstein, Gewirtz & Grossman, LLC.
Follow us for updates on LinkedIn, X, Facebook, or Instagram.
Contact Info
Peretz Bronstein, Esq. or Nathan Miller
Bronstein, Gewirtz & Grossman, LLC
917-590-0911 | [email protected]
Attorney advertising.
Prior results do not guarantee similar outcomes.
2026-03-05 17:056d ago
2026-03-05 12:006d ago
Varonis Systems, Inc. (VRNS) Shareholders Who Lost Money Have Opportunity to Lead Securities Fraud Lawsuit
, /PRNewswire/ -- Glancy Prongay Wolke & Rotter LLP announces that investors with losses have opportunity to lead the securities fraud class action lawsuit against Varonis Systems, Inc. ("Varonis" or the "Company") (NASDAQ: VRNS).
IF YOU SUFFERED A LOSS ON YOUR VARONIS INVESTMENTS, CLICK HERE BEFORE MARCH 9, 2026 (LEAD PLAINTIFF DEADLINE) TO PARTICIPATE IN THE SECURITIES FRAUD LAWSUIT
What Is The Lawsuit About?
The complaint filed alleges that, between February 4, 2025 and October 28, 2025, Defendants failed to disclose to investors that: (1) Varonis was ill-equipped to continue its ARR growth trajectory without maintaining a significantly high rate of quarterly conversions; and (2) as a result, Defendants' positive statements about the Company's business, operations, and prospects were materially misleading and/or lacked a reasonable basis at all relevant times.
Contact Us To Participate or Learn More:
If you wish to learn more about this action, or if you have any questions concerning this announcement or your rights or interests with respect to these matters, please contact us.
Charles Linehan, Esq.,
Glancy Prongay Wolke & Rotter LLP,
1925 Century Park East, Suite 2100,
Los Angeles California 90067
Email: [email protected]
Telephone: 310-201-9150 (Toll-Free: 888-773-9224)
Visit our website at www.glancylaw.com.
Follow us for updates on LinkedIn, Twitter, or Facebook.
If you inquire by email, please include your mailing address, telephone number and number of shares purchased.
To be a member of the class action you need not take any action at this time; you may retain counsel of your choice or take no action and remain an absent member of the class action.
This press release may be considered Attorney Advertising in some jurisdictions under the applicable law and ethical rules.
Contact Us:
Glancy Prongay Wolke & Rotter LLP,
1925 Century Park East, Suite 2100,
Los Angeles, CA 90067
Charles Linehan
Email: [email protected]
Telephone: 310-201-9150
Toll-Free: 888-773-9224
Visit our website at: www.glancylaw.com.
SOURCE Glancy Prongay Wolke & Rotter LLP
2026-03-05 17:056d ago
2026-03-05 12:006d ago
Bronstein, Gewirtz & Grossman LLC Urges Franklin BSP Realty Trust, Inc. Investors to Act: Class Action Filed Alleging Investor Harm
NEW YORK, March 05, 2026 (GLOBE NEWSWIRE) -- Bronstein, Gewirtz & Grossman, LLC, a nationally recognized investor-rights law firm, announces that a class action lawsuit has been filed against Franklin BSP Realty Trust, Inc. (NYSE: FBRT) and certain of its officers.
This lawsuit seeks to recover damages against Defendants for alleged violations of the federal securities laws on behalf of all persons and entities that purchased or otherwise acquired FBRT securities between November 5, 2024 and February 11, 2026, both dates inclusive (the “Class Period”). Such investors are encouraged to join this case by visiting the firm’s site: bgandg.com/FBRT.
FBRT Case Details
The Complaint alleges that throughout the Class Period, Defendants made false and/or misleading statements and/or failed to disclose that:
(1) Defendants recklessly overstated Franklin BSP Realty Trust’s prospects;
(2) Defendants recklessly overstated Franklin BSP Realty Trust’s ability to maintain the $0.355 dividend; and
(3) as a result, defendants’ statements about Franklin BSP Realty Trust’s business, operations, and prospects were materially false and/or lacked a reasonable basis at all relevant times. When the true details entered the market, the lawsuit claims that investors suffered damages.
What's Next for FBRT Investors?
A class action lawsuit has already been filed. If you wish to review a copy of the Complaint, you can visit the firm’s site: bgandg.com/FBRT or you may contact Peretz Bronstein, Esq. or his Client Relations Manager, Nathan Miller, of Bronstein, Gewirtz & Grossman, LLC at 917-590-0911. If you suffered a loss in FBRT you have until April 27, 2026, to request that the Court appoint you as lead plaintiff. Your ability to share in any recovery doesn't require that you serve as lead plaintiff.
No Cost to FBRT Investors
We, Bronstein, Gewirtz & Grossman LLC, represent investors in class actions on a contingency fee basis. That means we will ask the court to reimburse us for out-of-pocket expenses and attorneys’ fees, usually a percentage of the total recovery, only if we are successful.
Why Bronstein, Gewirtz & Grossman, LLC for FBRT Securities Class Action?
Bronstein, Gewirtz & Grossman, LLC is a nationally recognized firm that represents investors in securities fraud class actions and shareholder derivative suits. Our firm has recovered hundreds of millions of dollars for investors nationwide. More at www.bgandg.com
"Our practice centers on restoring investor capital and ensuring corporate accountability, which serves to uphold the essential integrity of the marketplace," said Peretz Bronstein, Founding Partner of Bronstein, Gewirtz & Grossman, LLC.
Follow us for updates on LinkedIn, X, Facebook, or Instagram.
Contact Info
Peretz Bronstein, Esq. or Nathan Miller
Bronstein, Gewirtz & Grossman, LLC
917-590-0911 | [email protected]
Attorney advertising.
Prior results do not guarantee similar outcomes.
2026-03-05 17:056d ago
2026-03-05 12:006d ago
OneIM Acquisition Corp. Announces the Separate Trading of its Class A Ordinary Shares and Warrants, Commencing March 6, 2026
, /PRNewswire/ -- OneIM Acquisition Corp. (Nasdaq: OIMAU) (the "Company") announced today that, commencing March 6, 2026, the holders of the units issued in the Company's initial public offering (the "Units"), each consisting of one Class A ordinary share of the Company, par value $0.0001 per share (the "Class A Ordinary Shares"), and one-sixth of one redeemable warrant of the Company (each, a "Warrant"), with each whole Warrant entitling the holder to purchase one Class A Ordinary Share for $11.50 per share, may elect to separately trade the Class A Ordinary Shares and the Warrants included in the Units. No fractional Warrants will be issued upon separation of the Units and only whole Warrants will trade. The Class A Ordinary Shares and the Warrants will trade on the Nasdaq Global Market under the symbols "OIM" and "OIMAW," respectively. Units not separated will continue to trade on the Nasdaq Global Market under the symbol "OIMAU."
This press release shall not constitute an offer to sell or the solicitation of an offer to buy the securities of the Company, nor shall there be any sale of these securities in any state or jurisdiction in which such offer, solicitation or sale would be unlawful prior to registration or qualification under the securities laws of any such state or jurisdiction.
About OneIM Acquisition Corp.
The Company is a blank check company incorporated as a Cayman Islands exempted company and formed for the purpose of effecting a merger, amalgamation, share exchange, asset acquisition, share purchase, reorganization or similar business combination with one or more businesses. The Company may pursue an acquisition opportunity in any business or industry or at any stage of its corporate evolution but is focused on completing a business combination with a target in industries or sectors in which the Company's management team and its affiliates have considerable knowledge and where the Company believes it has the ability to capture asymmetric risk/reward potential.
The Company's management team is led by Ioannis Pipilis, Chief Executive Officer and a member of the Board of Directors of the Company (the "Board"), and Grigorios Kapenis, Chief Financial Officer and a member of the Board. The Board also includes independent directors Mark DiPaolo and Antony Sheriff.
Please visit https://www.oneimacquisitioncorp.com/ for more information.
FORWARD-LOOKING STATEMENTS
This press release may include, and oral statements made from time to time by representatives of the Company may include, "forward-looking statements" within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. Statements regarding possible business combinations and the financing thereof, and related matters, as well as all other statements other than statements of historical fact included in this press release are forward-looking statements. When used in this press release, words such as "anticipate," "believe," "continue," "could," "estimate," "expect," "intend," "may," "might," "plan," "possible," "potential," "predict," "project," "should," "would" and similar expressions, as they relate to us or our management team, identify forward-looking statements. Such forward-looking statements are based on the beliefs of management, as well as assumptions made by, and information currently available to, the Company's management. Actual results could differ materially from those contemplated by the forward-looking statements as a result of certain factors detailed in the Company's filings with the Securities and Exchange Commission ("SEC"). All subsequent written or oral forward-looking statements attributable to us or persons acting on our behalf are qualified in their entirety by this paragraph. Forward-looking statements are subject to numerous conditions, many of which are beyond the control of the Company, including those set forth in the Risk Factors section of the Company's registration statement and prospectus for the Company's initial public offering filed with the SEC. The Company undertakes no obligation to update these statements for revisions or changes after the date of this release, except as required by law.
Investor Contact
OneIM Acquisition Corp.
Ioannis Pipilis, Chief Executive Officer
[email protected]
Media Contact
Greenbrook
Bree Taylor / Ksenia Galouchko
[email protected]
SOURCE OneIM Acquisition Corp.
2026-03-05 17:056d ago
2026-03-05 12:006d ago
Bronstein, Gewirtz & Grossman LLC Urges CoreWeave, Inc. Investors to Act: Class Action Filed Alleging Investor Harm
NEW YORK, March 05, 2026 (GLOBE NEWSWIRE) -- Bronstein, Gewirtz & Grossman, LLC, a nationally recognized investor-rights law firm, announces that a class action lawsuit has been filed against CoreWeave, Inc. (NASDAQ: CRWV) and certain of its officers.
This lawsuit seeks to recover damages against Defendants for alleged violations of the federal securities laws on behalf of all persons and entities that purchased or otherwise acquired CoreWeave securities between March 28, 2025 and December 15, 2025, both dates inclusive (the “Class Period”). Such investors are encouraged to join this case by visiting the firm’s site: bgandg.com/CRWV.
CoreWeave Case Details
The Complaint alleges that, throughout the Class Period, Defendants made materially false and misleading statements regarding the Company's business, operations, and prospects. Specifically, the Complaint alleges that Defendants made false and/or misleading statements and/or failed to disclose that:
(1)Defendants had overstated CoreWeave's ability to meet customer demand for its service; (2)Defendants materially understated the scope and severity of the risk that CoreWeave's reliance on a single third-party data center supplier presented for CoreWeave's ability to meet customer demand for its services; (3)the foregoing was reasonably likely to have a material negative impact on the Company's revenue; (4)as a result, the Company's public statements were materially false and misleading at all relevant times. What's Next for CoreWeave Investors?
A class action lawsuit has already been filed. If you wish to review a copy of the Complaint, you can visit the firm’s site: bgandg.com/CRWV. or you may contact Peretz Bronstein, Esq. or his Client Relations Manager, Nathan Miller, of Bronstein, Gewirtz & Grossman, LLC at 917-590-0911. If you suffered a loss in CoreWeave you have until March 13, 2026, to request that the Court appoint you as lead plaintiff. Your ability to share in any recovery doesn't require that you serve as lead plaintiff.
No Cost to CoreWeave Investors
We, Bronstein, Gewirtz & Grossman LLC, represent investors in class actions on a contingency fee basis. That means we will ask the court to reimburse us for out-of-pocket expenses and attorneys’ fees, usually a percentage of the total recovery, only if we are successful.
Why Bronstein, Gewirtz & Grossman, LLC for CoreWeave Securities Class Action?
Bronstein, Gewirtz & Grossman, LLC is a nationally recognized firm that represents investors in securities fraud class actions and shareholder derivative suits. Our firm has recovered hundreds of millions of dollars for investors nationwide. More at www.bgandg.com
"Our practice centers on restoring investor capital and ensuring corporate accountability, which serves to uphold the essential integrity of the marketplace," said Peretz Bronstein, Founding Partner of Bronstein, Gewirtz & Grossman, LLC.
Follow us for updates on LinkedIn, X, Facebook, or Instagram.
Contact Info
Peretz Bronstein, Esq. or Nathan Miller
Bronstein, Gewirtz & Grossman, LLC
917-590-0911 | [email protected]
Attorney advertising.
Prior results do not guarantee similar outcomes.
2026-03-05 17:056d ago
2026-03-05 12:006d ago
Bath & Body Works, Inc. (BBWI) Shareholders Who Lost Money Have Opportunity to Lead Securities Fraud Lawsuit
, /PRNewswire/ -- The Law Offices of Frank R. Cruz announces that investors with losses related to Bath & Body Works, Inc. ("Bath & Body Works" or the "Company") (NYSE: BBWI) have opportunity to lead the securities fraud class action lawsuit.
IF YOU ARE AN INVESTOR WHO SUFFERED A LOSS IN BATH & BODY WORKS, INC. (BBWI), CLICK HERE BEFORE MARCH 16, 2026 (THE LEAD PLAINTIFF DEADLINE) TO PARTICIPATE IN THE ONGOING SECURITIES FRAUD LAWSUIT.
What Is The Lawsuit About?
The complaint filed alleges that, between June 4, 2024 and November 19, 2025, Defendants failed to disclose to investors: (1) the Company's strategy of pursuing "adjacencies, collaborations and promotions" was not growing the customer base and/or delivering the level of growth in net sales touted; (2) as the Company's strategy of "adjacencies, collaborations and promotions" faltered, the Company relied on brand collaborations "to carry quarters" and obfuscate otherwise weak underlying financial results; (3) as a result, the Company was unlikely to meet its own previously issued financial guidance; (4) that, as a result of the foregoing, Defendants' positive statements about the Company's business, operations, and prospects were materially misleading and/or lacked a reasonable basis.
Contact Us To Participate or Learn More:
If you wish to learn more about this action, or if you have any questions concerning this announcement or your rights or interests with respect to these matters, please contact us.
The Law Offices of Frank R. Cruz,
Email us at: [email protected]
Call us at: 310-914-5007
Visit our website at: www.frankcruzlaw.com
Follow us for updates on Twitter: twitter.com/FRC_LAW.
If you inquire by email, please include your mailing address, telephone number, and number of shares purchased.
To be a member of the class action you need not take any action at this time; you may retain counsel of your choice or take no action and remain an absent member of the class action.
This press release may be considered Attorney Advertising in some jurisdictions under the applicable law and ethical rules.
SOURCE The Law Offices of Frank R. Cruz, Los Angeles
2026-03-05 17:056d ago
2026-03-05 12:006d ago
Bronstein, Gewirtz & Grossman LLC Urges Paysafe Limited Investors to Act: Class Action Filed Alleging Investor Harm
NEW YORK, March 05, 2026 (GLOBE NEWSWIRE) -- Bronstein, Gewirtz & Grossman, LLC, a nationally recognized investor-rights law firm, announces that a class action lawsuit has been filed against Paysafe Limited (NYSE: PSFE) and certain of its officers.
This lawsuit seeks to recover damages against Defendants for alleged violations of the federal securities laws on behalf of all persons and entities that purchased or otherwise acquired Paysafe securities between March 4, 2025 and November 12, 2025, both dates inclusive (the “Class Period”). Such investors are encouraged to join this case by visiting the firm’s site: bgandg.com/PSFE.
Paysafe Case Details
The complaint alleges defendants failed to disclose to investors:
(1) Paysafe’s ecommerce business had significant exposure to a single high risk client;
(2) as a result, the Company’s credit loss reserves and/or write-offs were understated;
(3) Paysafe had an undisclosed issue with higher risk Merchant Category Codes, making its client services difficult to bank;
(4) the foregoing issues were likely to have a material negative impact on the Company’s revenue growth and overall revenue mix;
(5) as a result, Paysafe was unlikely to meet its own previously issued financial guidance for fiscal year 2025; and
(6) that, as a result of the foregoing, Defendants’ positive statements about the Company’s business, operations, and prospects were materially misleading and/or lacked a reasonable basis.
What's Next for Paysafe Investors?
A class action lawsuit has already been filed. If you wish to review a copy of the Complaint, you can visit the firm’s site: bgandg.com/PSFE. or you may contact Peretz Bronstein, Esq. or his Client Relations Manager, Nathan Miller, of Bronstein, Gewirtz & Grossman, LLC at 917-590-0911. If you suffered a loss in Paysafe you have until April 7, 2026, to request that the Court appoint you as lead plaintiff. Your ability to share in any recovery doesn't require that you serve as lead plaintiff.
No Cost to Paysafe Investors
We, Bronstein, Gewirtz & Grossman LLC, represent investors in class actions on a contingency fee basis. That means we will ask the court to reimburse us for out-of-pocket expenses and attorneys’ fees, usually a percentage of the total recovery, only if we are successful.
Why Bronstein, Gewirtz & Grossman, LLC for Paysafe Securities Class Action?
Bronstein, Gewirtz & Grossman, LLC is a nationally recognized firm that represents investors in securities fraud class actions and shareholder derivative suits. Our firm has recovered hundreds of millions of dollars for investors nationwide. More at www.bgandg.com
"Our practice centers on restoring investor capital and ensuring corporate accountability, which serves to uphold the essential integrity of the marketplace," said Peretz Bronstein, Founding Partner of Bronstein, Gewirtz & Grossman, LLC.
Follow us for updates on LinkedIn, X, Facebook, or Instagram.
Contact Info
Peretz Bronstein, Esq. or Nathan Miller
Bronstein, Gewirtz & Grossman, LLC
917-590-0911 | [email protected]
Attorney advertising.
Prior results do not guarantee similar outcomes.
2026-03-05 17:056d ago
2026-03-05 12:006d ago
Kyndryl Holdings, Inc. (KD) Shareholders Who Lost Money Have Opportunity to Lead Securities Fraud Lawsuit
, /PRNewswire/ -- The Law Offices of Frank R. Cruz announces that investors with losses related to Kyndryl Holdings, Inc. ("Kyndryl" or the "Company") (NYSE: KD) have opportunity to lead the securities fraud class action lawsuit.
IF YOU ARE AN INVESTOR WHO SUFFERED A LOSS IN KYNDRYL HOLDINGS, INC. (KD), CLICK HERE BEFORE APRIL 13, 2026 (THE LEAD PLAINTIFF DEADLINE) TO PARTICIPATE IN THE ONGOING SECURITIES FRAUD LAWSUIT.
What Is The Lawsuit About?
The complaint filed alleges that, between August 7, 2024 and February 9, 2026, Defendants failed to disclose to investors that: (1) Kyndryls financial statements issued during the Class Period were materially misstated; (2) Kyndryl lacked adequate internal controls and at times materially understated issues with its internal controls; (3) as a result, Kyndryl would be unable to timely file its Quarterly Report on Form 10-Q for the quarter ended December 31, 2025; and (4) as a result, Defendants' positive statements about the Company's business, operations, and prospects were materially misleading and/or lacked a reasonable basis at all relevant times.
Contact Us To Participate or Learn More:
If you wish to learn more about this action, or if you have any questions concerning this announcement or your rights or interests with respect to these matters, please contact us.
The Law Offices of Frank R. Cruz,
Email us at: [email protected]
Call us at: 310-914-5007
Visit our website at: www.frankcruzlaw.com
Follow us for updates on Twitter: twitter.com/FRC_LAW.
If you inquire by email, please include your mailing address, telephone number, and number of shares purchased.
To be a member of the class action you need not take any action at this time; you may retain counsel of your choice or take no action and remain an absent member of the class action.
This press release may be considered Attorney Advertising in some jurisdictions under the applicable law and ethical rules.
SOURCE The Law Offices of Frank R. Cruz, Los Angeles
2026-03-05 17:056d ago
2026-03-05 12:006d ago
Deadline Alert: Paysafe Limited (PSFE) Shareholders Who Lost Money Urged To Contact Glancy Prongay Wolke & Rotter LLP About Securities Fraud Lawsuit
LOS ANGELES, March 05, 2026 (GLOBE NEWSWIRE) -- Glancy Prongay Wolke & Rotter LLP reminds investors of the upcoming April 7, 2026 deadline to file a lead plaintiff motion in the class action filed on behalf of investors who purchased or otherwise acquired Paysafe Limited (“Paysafe” or the “Company”) (NYSE: PSFE) securities between March 4, 2025 and November 12, 2025, inclusive (the “Class Period”).
IF YOU SUFFERED A LOSS ON YOUR PAYSAFE INVESTMENTS, CLICK HERE TO INQUIRE ABOUT POTENTIALLY PURSUING CLAIMS TO RECOVER YOUR LOSS UNDER THE FEDERAL SECURITIES LAWS.
What Happened?
On November 13, 2025, before the market opened, Paysafe announced third quarter financial results, including revenue of $433.8 million, which missed consensus estimates by $5.8 million, and a net loss of $87.7 million, a steep drop from the prior year period wherein the Company’s net loss was only $12.98 million. The Company also slashed full year 2025 expected revenue to $17 million at the midpoint, and adjusted EPS $0.50 at the midpoint.
The Company further revealed that its credit loss expense for the quarter was $13,220 “primarily [as] the result of a specific provision for expected chargebacks related to an individual merchant in the Merchant Solutions segment.” The report revealed write-offs of $9,924 “driven by the write off of irrecoverable amounts receivable in the Merchant Solutions segment.”
On the same date, the Company held an earnings call during which CEO, Bruce Lowthers revealed the Company “had a last-minute client that had to shut down that caused several million-dollar write-down in Q3.” Lowthers further revealed the Company is in a market tier with “higher risk MCC [Merchant Category Codes] codes.” Lowthers explained “those things sometimes are a little difficult to bank” and “sometimes the banks aren’t open to the additional risk” “so, we’ve had a little bit of challenge with that with some of those MCC codes.”
On this news, Paysafe’s stock price fell $2.80, or 27.6%, to close at $7.36 per share on November 13, 2025, on unusually heavy trading volume.
What Is The Lawsuit About?
The complaint filed in this class action alleges that throughout the Class Period, Defendants made materially false and/or misleading statements, as well as failed to disclose material adverse facts about the Company’s business, operations, and prospects. Specifically, Defendants failed to disclose to investors: (1) Paysafe’s ecommerce business had significant exposure to a single high risk client; (2) as a result, the Company’s credit loss reserves and/or write-offs were understated; (3) Paysafe had an undisclosed issue with higher risk Merchant Category Codes, making its client services difficult to bank; (4) the foregoing issues were likely to have a material negative impact on the Company’s revenue growth and overall revenue mix; (5) as a result, Paysafe was unlikely to meet its own previously issued financial guidance for fiscal year 2025; and (6) that, as a result of the foregoing, Defendants’ positive statements about the Company’s business, operations, and prospects were materially misleading and/or lacked a reasonable basis.
If you purchased or otherwise acquired Paysafe securities during the Class Period, you may move the Court no later than April 7, 2026 to request appointment as lead plaintiff in this putative class action lawsuit.
Contact Us To Participate or Learn More:
If you wish to learn more about this action, or if you have any questions concerning this announcement or your rights or interests with respect to these matters, please contact us:
Charles Linehan, Esq.,
Glancy Prongay Wolke & Rotter LLP,
1925 Century Park East, Suite 2100,
Los Angeles California 90067
Email: [email protected]
Telephone: 310-201-9150,
Toll-Free: 888-773-9224
Visit our website at www.glancylaw.com.
Follow us for updates on LinkedIn, Twitter, or Facebook.
If you inquire by email, please include your mailing address, telephone number and number of shares purchased.
To be a member of the class action you need not take any action at this time; you may retain counsel of your choice or take no action and remain an absent member of the class action.
This press release may be considered Attorney Advertising in some jurisdictions under the applicable law and ethical rules.
Contact Us:
Glancy Prongay Wolke & Rotter LLP,
1925 Century Park East, Suite 2100
Los Angeles, CA 90067
Charles Linehan
Email: [email protected]
Telephone: 310-201-9150
Toll-Free: 888-773-9224
Visit our website at: www.glancylaw.com.
2026-03-05 17:056d ago
2026-03-05 12:006d ago
Deadline Alert: NuScale Power Corporation (SMR) Shareholders Who Lost Money Urged To Contact Glancy Prongay Wolke & Rotter LLP About Securities Fraud Lawsuit
LOS ANGELES, March 05, 2026 (GLOBE NEWSWIRE) -- Glancy Prongay Wolke & Rotter LLP reminds investors of the upcoming April 20, 2026 deadline to file a lead plaintiff motion in the class action filed on behalf of investors who purchased or otherwise acquired NuScale Power Corporation (“NuScale” or the “Company”) (NYSE: SMR) common stock between May 13, 2025 and November 6, 2025, inclusive (the “Class Period”).
IF YOU SUFFERED A LOSS ON YOUR NUSCALE INVESTMENTS, CLICK HERE TO INQUIRE ABOUT POTENTIALLY PURSUING CLAIMS TO RECOVER YOUR LOSS UNDER THE FEDERAL SECURITIES LAWS.
What Happened?
On November 6, 2025, after market hours, NuScale disclosed that the Company’s general and administrative expenses had increased more than 3,000%, to $519 million during its third fiscal quarter compared to $17 million in the prior year period. The surge was largely due to the Company’s payment of $495 million to ENTRA1 Energy LLC for its Tennessee Valley Authority agreement. As a result, NuScale’s quarterly net loss rose to $532 million, up from $46 million in the prior year period.
Following the Company’s earnings announcement, analysts at Guggenheim Securities published a report stating that ENTRA1 was a “3-year old company that has never built, financed or operated anything” and that its available information revealed nothing “regarding the company’s history, management team, size or capitalization.” The report further stated that a “more accurate description” of ENTRA1 would be “that it is an entity supporting the activities of a single individual, specifically [its CEO and Chairman, Wadie Habboush].”
On this news, NuScale’s stock price fell $4.03, or 12.4%, over two consecutive trading days to close at $28.43 per share on November 10, 2025, thereby injuring investors.
What Is The Lawsuit About?
The complaint filed in this class action alleges that throughout the Class Period, Defendants made materially false and/or misleading statements, as well as failed to disclose material adverse facts about the Company’s business, operations, and prospects. Specifically, Defendants failed to disclose to investors that: (1) ENTRA1 had never built, financed, or operated any significant projects—let alone projects in the highly technical and complicated field of nuclear power generation—during its entire operating history; (2) NuScale had entrusted its commercialization, distribution, and deployment of its NuScale Power Modules, and hundreds of millions of dollars of NuScale capital to an entity that lacked any significant prior experience owning, financing, or operating nuclear energy generation facilities; (3) the purported experience and qualifications attributed to ENTRA1 by defendants during the Class Period in fact referred to the purported experience and qualifications of the principals of the Habboush Group, a distinct entity without significant experience in the field of nuclear power generation; (4) as a result, NuScale's commercialization strategy was exposed to material, undisclosed risks of failure, delays, regulatory challenges, or other negative setbacks; and (5) as a result, Defendants’ positive statements about the Company’s business, operations, and prospects were materially misleading and/or lacked a reasonable basis at all relevant times.
If you purchased or otherwise acquired NuScale common stock during the Class Period, you may move the Court no later than April 20, 2026 to request appointment as lead plaintiff in this putative class action lawsuit.
Contact Us To Participate or Learn More:
If you wish to learn more about this action, or if you have any questions concerning this announcement or your rights or interests with respect to these matters, please contact us:
Charles Linehan, Esq.,
Glancy Prongay Wolke & Rotter LLP,
1925 Century Park East, Suite 2100,
Los Angeles California 90067
Email: [email protected]
Telephone: 310-201-9150,
Toll-Free: 888-773-9224
Visit our website at www.glancylaw.com.
Follow us for updates on LinkedIn, Twitter, or Facebook.
If you inquire by email, please include your mailing address, telephone number and number of shares purchased.
To be a member of the class action you need not take any action at this time; you may retain counsel of your choice or take no action and remain an absent member of the class action.
This press release may be considered Attorney Advertising in some jurisdictions under the applicable law and ethical rules.
Contact Us:
Glancy Prongay Wolke & Rotter LLP,
1925 Century Park East, Suite 2100
Los Angeles, CA 90067
Charles Linehan
Email: [email protected]
Telephone: 310-201-9150
Toll-Free: 888-773-9224
Visit our website at: www.glancylaw.com.
2026-03-05 17:056d ago
2026-03-05 12:006d ago
Deadline Alert: BellRing Brands, Inc. (BRBR) Shareholders Who Lost Money Urged To Contact Glancy Prongay Wolke & Rotter LLP About Securities Fraud Lawsuit
LOS ANGELES, March 05, 2026 (GLOBE NEWSWIRE) -- Glancy Prongay Wolke & Rotter LLP reminds investors of the upcoming March 23, 2026 deadline to file a lead plaintiff motion in the class action filed on behalf of investors who purchased or otherwise acquired BellRing Brands, Inc. ("BellRing " or the Company") (NYSE: BRBR) securities between November 19, 2024 and August 4, 2025, inclusive (the “Class Period”).
IF YOU SUFFERED A LOSS ON YOUR BELLRING INVESTMENTS, CLICK HERE TO INQUIRE ABOUT POTENTIALLY PURSUING CLAIMS TO RECOVER YOUR LOSS UNDER THE FEDERAL SECURITIES LAWS.
What Happened?
On May 6, 2025, BellRing disclosed that “several key retailers lowered their weeks of supply on hand, which is expected to be a mid-single-digit headwind to [the Company’s] third quarter growth,” lowering expectations of third quarter net sales growth to low single digits, further stating that retailers had been “hoarding inventory to make sure that they didn’t run out of stock on shelf” and “protecting themselves coming out of capacity constraints.”
On this news, BellRing’s stock price fell $14.88, or 19%, to close at $63.55 per share on May 6, 2025, thereby injuring investors.
Then, on August 4, 2025, BellRing released its third quarter 2025 financial results and lowered its net sales outlook for fiscal 2025, citing competitive headwinds. In an earnings call the following day, the Company stated that although BellRing had secured new inventory space with a large club retailer, “several other competitors gained . . .space as well. So we’re assuming this increases some competitive pressure in club[.]”
On this news, BellRing’s stock price fell $17.46, or 32.6%, to close at $36.18 per share on August 5, 2025, thereby injuring investors further.
What Is The Lawsuit About?
The complaint filed in this class action alleges that throughout the Class Period, Defendants made materially false and/or misleading statements, as well as failed to disclose material adverse facts about the Company’s business, operations, and prospects. Specifically, Defendants failed to disclose to investors that: (1) contrary to Defendants’ repeated representations, their strong sales results did not reflect increased end-consumer demand or brand momentum; (2) instead, customers accumulated excess inventory as a safeguard against product shortages that had previously constrained BellRing’s supply; (3) Once customers gained confidence that product shortages were a thing of the past, they promptly reduced their inventory by selling through existing products and cutting back on new orders; (4) Following the destocking, the Company admitted that competitive pressures were materially weakening demand; and (5) as a result, Defendants’ positive statements about the Company’s business, operations, and prospects were materially misleading and/or lacked a reasonable basis at all relevant times.
If you purchased or otherwise acquired BellRing securities during the Class Period, you may move the Court no later than March 23, 2026 to request appointment as lead plaintiff in this putative class action lawsuit.
Contact Us To Participate or Learn More:
If you wish to learn more about this action, or if you have any questions concerning this announcement or your rights or interests with respect to these matters, please contact us:
Charles Linehan, Esq.,
Glancy Prongay Wolke & Rotter LLP
1925 Century Park East, Suite 2100,
Los Angeles California 90067
Email: [email protected]
Telephone: 310-201-9150,
Toll-Free: 888-773-9224
Visit our website at www.glancylaw.com.
Follow us for updates on LinkedIn, Twitter, or Facebook.
If you inquire by email, please include your mailing address, telephone number and number of shares purchased.
To be a member of the class action you need not take any action at this time; you may retain counsel of your choice or take no action and remain an absent member of the class action.
This press release may be considered Attorney Advertising in some jurisdictions under the applicable law and ethical rules.
Contact Us:
Glancy Prongay Wolke & Rotter LLP
1925 Century Park East, Suite 2100
Los Angeles, CA 90067
Charles Linehan
Email: [email protected]
Telephone: 310-201-9150
Toll-Free: 888-773-9224
Visit our website at: www.glancylaw.com.
2026-03-05 17:056d ago
2026-03-05 12:006d ago
Deadline Alert: Corcept Therapeutics Incorporated (CORT) Shareholders Who Lost Money Urged To Contact Glancy Prongay Wolke & Rotter LLP About Securities Fraud Lawsuit
LOS ANGELES, March 05, 2026 (GLOBE NEWSWIRE) -- Glancy Prongay Wolke & Rotter LLP reminds investors of the upcoming April 21, 2026 deadline to file a lead plaintiff motion in the class action filed on behalf of investors who purchased or otherwise acquired Corcept Therapeutics Incorporated (“Corcept” or the “Company”) (NASDAQ: CORT) common stock between October 31, 2024 and December 30, 2025, inclusive (the “Class Period”).
IF YOU SUFFERED A LOSS ON YOUR CORCEPT INVESTMENTS, CLICK HERE TO INQUIRE ABOUT POTENTIALLY PURSUING CLAIMS TO RECOVER YOUR LOSS UNDER THE FEDERAL SECURITIES LAWS.
What Happened?
On December 31, 2025, Corcept announced the U.S. Food and Drug Administration (“FDA”) had issued a Complete Response Letter (“CRL”), declining to approve the Company’s New Drug Application (“NDA”) for relacorilant as a treatment for patients with hypercortisolism, stating that the FDA had “concluded it could not arrive at a favorable benefit-risk assessment for relacorilant without Corcept providing additional evidence of effectiveness.” The Company stated it was “surprised and disappointed by this outcome.”
On this news, Corcept’s stock price fell $35.40 per share, or 50.42%, to close at $34.80 per share on December 31, 2025.
Then, on January 30, 2026, the FDA published an updated CRL regarding Corcept’s relacorilant NDA. The letter revealed that “[d]uring the pre-submission meetings, [the FDA] informed [Corcept] on several occasions of [its] concerns about the adequacy of the clinical development program to assess the effect of relacorilant” and “to expect significant review issues if [Corcept] were to submit [its] application.”
What Is The Lawsuit About?
The complaint filed in this class action alleges that throughout the Class Period, Defendants made materially false and/or misleading statements, as well as failed to disclose material adverse facts about the Company’s business, operations, and prospects. Specifically, Defendants failed to disclose to investors that: (1) the FDA had told Corcept that it had concerns about the adequacy of the program assessing relacorilant’s effectiveness in treating hypertension in patients with hypercortisolism, including the design of its pivotal “GRACE” trial study; (2) the FDA had further told Corcept to expect significant issues with the review if Corcept was to submit the NDA; and (3) as a result, Defendants’ positive statements about the Company’s business, operations, and prospects were materially misleading and/or lacked a reasonable basis at all relevant times.
If you purchased or otherwise acquired Corcept common stock during the Class Period, you may move the Court no later than April 21, 2026 to request appointment as lead plaintiff in this putative class action lawsuit.
Contact Us To Participate or Learn More:
If you wish to learn more about this action, or if you have any questions concerning this announcement or your rights or interests with respect to these matters, please contact us:
Charles Linehan, Esq.,
Glancy Prongay Wolke & Rotter LLP,
1925 Century Park East, Suite 2100,
Los Angeles California 90067
Email: [email protected]
Telephone: 310-201-9150,
Toll-Free: 888-773-9224
Visit our website at www.glancylaw.com.
Follow us for updates on LinkedIn, Twitter, or Facebook.
If you inquire by email, please include your mailing address, telephone number and number of shares purchased.
To be a member of the class action you need not take any action at this time; you may retain counsel of your choice or take no action and remain an absent member of the class action.
This press release may be considered Attorney Advertising in some jurisdictions under the applicable law and ethical rules.
Contact Us:
Glancy Prongay Wolke & Rotter LLP,
1925 Century Park East, Suite 2100
Los Angeles, CA 90067
Charles Linehan
Email: [email protected]
Telephone: 310-201-9150
Toll-Free: 888-773-9224
Visit our website at: www.glancylaw.com.
2026-03-05 17:056d ago
2026-03-05 12:006d ago
Crude Oil at 52-Week High: Stay Nimble for Opportunities Amid Stronger Volatility
@CharlesSchwab's Liz Ann Sonders says the commodity space is all about crude. She urges inventors to brace for volatility so long as oil remains above $74 even with "resiliency" masking some of the volatile moves.
2026-03-05 17:056d ago
2026-03-05 12:006d ago
Sin Stock Investing: Are There Opportunities Beyond Ethical Debate?
Sin stocks refer to shares of companies that operate in industries often considered socially controversial, such as alcohol, tobacco, gambling and sometimes firearms or cannabis. Despite the ethical debate surrounding them, these businesses tend to generate steady demand and strong cash flows, making them a notable segment of the equity market.
Sin stock investing works much like traditional stock investing. Investors purchase shares of companies whose products fall within these categories and seek returns through capital appreciation and dividends. Major players in these industries include tobacco giant Altria Group (MO - Free Report) , beverage leader Diageo Plc (DEO - Free Report) and leading casino operators. Because their products often have loyal consumer bases, these companies tend to maintain relatively stable sales even amid economic downturns.
However, investing in sin stocks comes with certain risks. These industries face strict government regulations, higher taxes, legal scrutiny and advertising restrictions. In addition, some institutional investors avoid these companies due to environmental, social and governance (ESG) considerations, which can influence valuations and investor sentiment.
Why Some Investors Choose Sin StocksOne reason investors consider sin stocks is their defensive characteristics. Demand for products like alcohol and cigarettes typically remains resilient regardless of economic cycles. Companies operating in industries such as alcohol, tobacco and gambling often benefit from consistent consumer demand. This stability often translates into consistent revenue streams and attractive dividend payouts. Many sin-stock companies also benefit from strong brand loyalty and pricing power, which can support long-term profitability.
Another reason investors choose sin stocks is their high profitability and dividend potential. These companies often enjoy strong pricing power and relatively predictable cash flows, enabling them to return a significant portion of profits to shareholders through dividends and share buybacks. As a result, sin stocks are sometimes viewed as defensive investments within a diversified portfolio.
Additionally, the growing focus on ESG investing has led many institutional funds to avoid these sectors. This reduced participation can occasionally leave sin stocks undervalued, creating opportunities for investors who prioritize financial returns over ethical considerations.
Trends in Sin Stock SectorsSin stock sectors are evolving as consumer behavior, technology and regulations reshape traditional industries such as alcohol, tobacco and gambling. One major trend is product innovation and diversification. Tobacco companies are shifting toward reduced-risk products like vaping devices, heated tobacco and smokeless alternatives to address health concerns and declining cigarette consumption.
Another key trend is premiumization in the alcohol industry. Consumers are increasingly opting for premium, craft and specialty beverages, while demand for low and no-alcohol drinks is also growing. This shift allows companies to maintain strong pricing power and expand profit margins.
The digital transformation of gambling is also reshaping the sector. Online betting, mobile gaming platforms and legalized sports wagering are creating revenue streams and attracting younger consumers, significantly expanding the market.
At the same time, regulatory changes and higher “sin taxes” remain a defining factor for these industries, influencing profitability and stock performance. Governments often impose higher taxes on tobacco, alcohol and gaming to discourage consumption while raising revenues. Overall, while sin stock sectors face regulatory scrutiny, innovation, digital expansion and shifting consumer preferences continue to shape their long-term growth prospects.
If you are looking to capitalize on this trend, our Sin Stocks Screen makes it easy to identify high-potential stocks such as Monarch Casino & Resort (MCRI - Free Report) , Philip Morris International (PM - Free Report) and Constellation Brands, Inc. (STZ - Free Report) .
Explore 36 cutting-edge investment themes with Zacks Thematic Investing Screens and uncover your next big opportunity.
Monarch Casino presents a solid long-term investment case, driven by its premium regional resort strategy and disciplined operations. The company focuses on enhancing guest experiences through property upgrades, modern gaming amenities and high-quality hospitality offerings, helping strengthen its competitive position in key markets.
Management continues to prioritize targeted marketing, operational efficiency and reinvestment in its flagship properties to attract higher-value customers and boost spending per visit. Its concentrated portfolio allows greater control over service quality and cost management. With consistent property improvements and a focus on premium experiences, the Zacks Rank #2 (Buy) company is well-positioned to sustain visitation growth and generate stable cash flows over the long term. You can see the complete list of today’s Zacks #1 Rank (Strong Buy) stocks here.
Philip Morris offers a strong long-term investment case, driven by its transformation toward a smoke-free future. The company holds a leading global position, supported by powerful brands, extensive distribution and strong pricing power. Its strategy focuses on expanding reduced-risk products, such as heated tobacco and nicotine pouches, which are gaining traction among adult consumers.
Management continues to invest in innovation, research and brand development to accelerate the adoption of these next-generation products across global markets. With strong cash generation and growing consumer acceptance of smoke-free alternatives, Philip Morris is well-positioned to sustain long-term growth and deliver durable shareholder value. The company currently sports a Zacks Rank #2.
Constellation Brands’ fundamental strength lies in its dominant position in the U.S. high-end beer category, supported by industry-leading brands such as Modelo, Corona and Pacifico. Despite a pressured consumer backdrop, STZ continues to outperform the beer category and gain market share across 49 of 50 states, underscoring strong brand equity and customer loyalty. The company’s strategy emphasizes pricing discipline, cost-saving initiatives and optimized price-pack architecture, which have helped sustain the beer operating margin, even amid volume and cost headwinds.
STZ’s 7 million hectoliter capacity expansion through fiscal 2028, modular capital deployment and focus on distribution gains support structural growth. Strong cash flows and operational flexibility reinforce its ability to drive durable earnings and shareholder returns. The company currently has a Zacks Rank #2.
2026-03-05 17:056d ago
2026-03-05 12:006d ago
Clover Health Enters Collaboration to Be Part of CMS Aligned Network
Key Takeaways Clover Health partnered with Kno2 to become the first payer live on a CMS Aligned Network.CLOV will deliver real-time clinical and claims data via standardized FHIR formats for patient requests.Clover Health expects the move to drive adoption of Clover Assistant and support data-driven care. Clover Health Investments (CLOV - Free Report) has announced a partnership with healthcare’s leading communication network, Kno2, to become the first payer live on a CMS Aligned Network and TEFCA. This will enable Clover Health to provide real-time patient access to claims data on a CMS Aligned Network.
The CMS Aligned Network is a government initiative to create an Interoperability Framework for health data networks. This is a voluntary blueprint for modern health data exchange to deliver real-time results and enable patients to access their electronic medical information anywhere using applications of their choice. The network will also help health providers to get information on patient’s full treatment history. Payers, including CMS, can query for relevant data tied to a claim submitted in the last 60 days and receive clinical data for that encounter.
The TEFCA is another government initiative, mandated by the 21st Century Cures Act, designed to create a secure, nationwide and interoperable system for health information exchange. It establishes a "network of networks" using Qualified Health Information Networks (QHINs) to connect providers, patients and payers.
CLOV’s Price PerformanceShare of Clover Health closed 8% higher on March 4, following the announcement of the collaboration. The company’s shares have declined 21.5% in the past six months compared with the industry’s 34.8% fall. The S&P 5400 Index is up 6.4% in the same time period.
Image Source: Zacks Investment Research
With this collaboration with Kno2, Clover Health becomes the first payer to be live on a CMS Aligned Network for patient-directed requests, leading the way in bringing national interoperability frameworks into production. The early adoption by the company may lead to higher demand for Clover Assistant, which collects patient data from different players across the healthcare ecosystem, supporting early identification and better clinical decision-making, potentially leading to improved health outcomes and chronic disease management.
More on the NewsAs part of this partnership, Clover Health will respond in real time to patient-directed requests for clinical and claims data using standardized FHIR (USCDI v3) formats. Under the CMS Aligned Networks framework, Kno2 securely routes patient-directed requests across the network, Counterpart Health enables the standardized exchange of data and Clover Health responds as the payer with structured clinical and claims information.
Counterpart Health is CLOV’s technology and services business that helps physicians, payers and risk-based entities gain access to a wide range of clean clinical data at scale.
CLOV believes that secure, real-time access to clinical and claims information by members will lead to transparency and control, including easier sharing with caregivers and providers, thereby providing a better understanding of their own health journey.
Industry ProspectsPer a report from Grand View Research, the global healthcare data integration market size was valued at $1.05 billion in 2022, which is expected to witness a CAGR of 14.5% to reach $3.11 billion in 2030. The growth is likely to be driven by the increasing importance of amalgamating data in providing patient care, the rapidly rising demand for value-based healthcare and streamlining information access.
Clover Health is gaining momentum in the Medicare Advantage market, fueled by strong membership growth. The company’s AI-driven Clover Assistant platform has demonstrated a strong clinical impact, reducing hospitalizations and re-admissions in chronic heart failure cases, while also supporting Counterpart Health, its emerging SaaS revenue stream. CLOV’s participation in CMS Aligned Network should further accelerate the adoption of company’s services, boosting its potential in this rapidly growing market.
Recent News From CLOVLast month, Clover Health announced fourth-quarter results, wherein sales beat market expectations. The robust uptick in consolidated revenues and key Insurance segment revenues was encouraging. The company emphasized its continued progress in adjusted EBITDA profitability and a controlled underlying medical cost trend while delivering robust membership and revenue growth within Medicare Advantage. The company achieved full-year adjusted EBITDA profitability while growing Medicare Advantage membership 38% year over year.
CLOV entered 2026 with more than 95% AEP retention and strong Clover Assistant engagement, with two-thirds of members receiving Assistant-powered care in 2025. Management expects 2026 to mark its first full year of GAAP net income profitability, supported by stronger cohort economics.
CLOV’s Zacks Rank & Stocks to ConsiderClover Health currently carries a Zacks Rank # 3 (Hold). Some better-ranked stocks from the same medical industry are Globus Medical (GMED - Free Report) , Pacific Biosciences of California (PACB - Free Report) and Edwards Lifesciences (EW - Free Report) .
Globus Medical, sporting a Zacks Rank #1 (Strong Buy) at present, reported fourth-quarter 2025 adjusted EPS of $1.28, beating the Zacks Consensus Estimate by 20.8%. Revenues of $826 million surpassed the Zacks Consensus Estimate by 4.9%. You can see the complete list of today’s Zacks #1 Rank stocks here.
GMED has an estimated long-term earnings growth rate of 9.6% compared with the industry’s 14% rise. The company beat earnings estimates in each of the trailing four quarters, with the average surprise being 13.2%.
Pacific Biosciences of California, currently flaunting a Zacks Rank of 1, reported a fourth-quarter 2025 adjusted loss per share of 12 cents, which surpassed the Zacks Consensus Estimate by 36.8%. Revenues of $45 million beat the Zacks Consensus Estimate by 9.4%.
PACB has an estimated earnings decline rate of 1.9% against the industry’s 11.4% improvement. The company beat earnings estimates in each of the trailing four quarters, with the average surprise being 27.7%.
Edwards Lifesciences, currently carrying a Zacks Rank #2 (Buy), reported a second-quarter fiscal 2026 adjusted EPS of 58 cents, which missed the Zacks Consensus Estimate by 6.5%. Revenues of $1.57 billion beat the Zacks Consensus Estimate by 2%.
EW has an estimated long-term earnings growth rate of 12.9% compared with the industry’s 14% rise. The company beat earnings estimates in three of the trailing four quarters and missed once, with the average surprise being 5.5%.
2026-03-05 17:056d ago
2026-03-05 12:006d ago
Here's Why You Should Add Cardinal Health Stock to Your Portfolio Now
Key Takeaways CAH posted strong fiscal Q2 as pharma and specialty revenue rose 19% to $61B and segment profit jumped 29%.CAH's specialty sales to exceed $50B in fiscal 2026, driven by oncology, urology and specialty distribution.CAH's Nuclear & Precision Health, at-Home and OptiFreight units saw 34% revenue and 52% profit growth. Cardinal Health (CAH - Free Report) is well-positioned for continued growth, thanks to the expansion of its speciality portfolio. The firm delivered strong fiscal second-quarter results, fueled by robust demand in pharmaceutical distribution and accelerating specialty services. Growth in theranostics, at-home solutions and logistics businesses, alongside improving medical segment performance, continues to strengthen CAH’s long-term earnings outlook.
This Zacks Rank #2 (Buy) company’s shares have gained 49.2% in the past six months compared with the industry’s 23.3% growth. The S&P 500 has jumped 6.4% during the same time frame.
The leading provider of healthcare services and products has a market capitalization of $53.26 billion. It projects 15% growth over the next five years and expects to witness continued improvement in its business going forward. Cardinal Health’s earnings surpassed the Zacks Consensus Estimate in each of the trailing four quarters, delivering an average surprise of 9.3%.
Image Source: Zacks Investment Research
Let’s delve deeper.
UpsidesStrong Momentum in Pharmaceutical and Specialty Solutions: Cardinal Health delivered robust growth in its core Pharmaceutical and Specialty Solutions segment, with revenue rising 19% to $61 billion and segment profit increasing 29% in the second quarter of fiscal 2026. Growth was supported by strong demand across brand, specialty and generics, along with contributions from specialty distribution, MSO platforms and biopharma services. Management highlighted that specialty revenues are expected to exceed $50 billion in fiscal 2026, underscoring the company’s successful pivot toward higher-margin specialty therapies, such as oncology and urology. This expansion strengthens Cardinal Health’s competitive positioning in the fast-growing specialty pharmaceutical ecosystem.
High-Growth Adjacent Businesses Drive Profit Diversification: Cardinal Health’s “Other” growth businesses — Nuclear and Precision Health Solutions, at-Home Solutions and OptiFreight Logistics — delivered 34% revenue growth and 52% profit growth in the fiscal second quarter. Demand was fueled by structural healthcare trends, including theranostics adoption, home-based care expansion and supply chain optimization. Theranostics alone generated more than 30% revenue growth, supported by a pipeline of more than 70 products. These segments provide faster growth and higher margins compared with traditional distribution, allowing Cardinal Health to diversify earnings streams and reduce reliance on its low-margin core pharmaceutical distribution business.
Improving Profitability in the GMPD Segment Turnaround: Cardinal Health’s Global Medical Products and Distribution (GMPD) segment showed tangible progress in its turnaround strategy, with segment profit rising from $18 million to $37 million year over year. The improvement reflects operational restructuring, cost optimization and stronger demand for Cardinal Health branded products, which grew 10% in the United States. Management also emphasized improved service levels and supply chain efficiency following manufacturing and logistics investments. If these operational gains persist, the GMPD business could transition from a long-standing drag on earnings to a modest contributor to profitability and margin expansion.
DownsidesProfit Growth Moderation Expected in the Second Half: Despite strong first-half results in fiscal 2026, Cardinal Health expects profit growth in the Pharma segment to moderate to mid-teens levels in the second half. The slowdown reflects difficult comparisons from onboarding $10 billion in new customers last year and the anniversary of prior acquisitions. While demand remains healthy, the normalization of these one-time growth drivers could temper earnings momentum. Investors may view this deceleration as a signal that recent growth levels were partly driven by temporary tailwinds rather than purely sustainable organic expansion.
Tariffs and Supply Chain Costs Weigh on Medical Segment: The GMPD segment continues to face external cost pressures, particularly from tariffs affecting medical product sourcing. Although cost optimization initiatives helped offset some of the impact, tariffs still represented a net headwind to segment profitability during the quarter. Given the global nature of medical product manufacturing and sourcing, persistent geopolitical trade policies or supply chain disruptions could increase procurement costs, compress margins and limit the pace of profitability recovery within the GMPD turnaround plan.
Limited Margin Expansion in Core Distribution Model: Cardinal Health’s pharmaceutical distribution business, while large and stable, structurally operates with thin margins and high volume dependence. Management acknowledged that major drug categories such as GLP-1 therapies contribute meaningfully to revenue growth but have a limited impact on underlying profitability. This reflects the inherent economics of pharmaceutical distribution, where scale drives revenue but margins remain compressed. As a result, sustained earnings expansion increasingly depends on specialty services and adjacent businesses rather than the core distribution segment alone.
Estimate TrendCardinal Health has been witnessing an improving estimate revision trend for 2026. Over the past 30 days, the Zacks Consensus Estimate for earnings per share (EPS) has improved 2.7% to $10.31.
The Zacks Consensus Estimate for the fiscal 2026 third-quarter revenues is pegged at $62.42 billion, indicating a 13.7% improvement from the year-ago reported number. The Zacks Consensus Estimate for EPS is pinned at $2.80, implying a year-over-year gain of 19.2%.
Other Stocks to ConsiderSome other top-ranked stocks from the same medical industry are Globus Medical (GMED - Free Report) , Pacific Biosciences of California (PACB - Free Report) and Edwards Lifesciences (EW - Free Report) .
Globus Medical, sporting a Zacks Rank #1 (Strong Buy) at present, reported fourth-quarter 2025 adjusted EPS of $1.28, beating the Zacks Consensus Estimate by 20.8%. Revenues of $826 million surpassed the Zacks Consensus Estimate by 4.9%. You can see the complete list of today’s Zacks #1 Rank stocks here.
GMED has an estimated long-term earnings growth rate of 9.6% compared with the industry’s 14% rise. The company beat earnings estimates in each of the trailing four quarters, with the average surprise being 13.2%.
Pacific Biosciences of California, currently flaunting a Zacks Rank of 1, reported a fourth-quarter 2025 adjusted loss per share of 12 cents, which surpassed the Zacks Consensus Estimate by 36.8%. Revenues of $45 million beat the Zacks Consensus Estimate by 9.4%.
PACB has an estimated earnings decline rate of 1.9% against the industry’s 11.4% improvement. The company beat earnings estimates in each of the trailing four quarters, with the average surprise being 27.7%.
Edwards Lifesciences, currently carrying a Zacks Rank #2 (Buy), reported a second-quarter fiscal 2026 adjusted EPS of 58 cents, which missed the Zacks Consensus Estimate by 6.5%. Revenues of $1.57 billion beat the Zacks Consensus Estimate by 2%.
EW has an estimated long-term earnings growth rate of 12.9% compared with the industry’s 14% rise. The company beat earnings estimates in three of the trailing four quarters and missed once, with the average surprise being 5.5%.
2026-03-05 17:056d ago
2026-03-05 12:026d ago
Build‑A‑Bear's New Frosted Animal Cookie Collection Turns Sweet Nostalgia into a Squeezable Treat
A sprinkle‑covered throwback meets Build‑A‑Bear's signature personalization
, /PRNewswire/ -- Build‑A‑Bear Workshop, the beloved experiential retailer known for "adding a little more heart to life," is serving up a playful dose of nostalgia with the launch of its new Frosted Animal Cookie Collection, inspired by the iconic pink‑and‑white frosted animal cookies topped with colorful sprinkles. The new line of plush brings a beloved childhood treat into the brand's signature make‑your‑own experience, blending whimsical design with personalization and heart.
Build-A-Bear's Frosted Animal Cookie Collection These Frosted Animal Cookie friends, now available at Build-A-Bear Workshop locations and online, feature frosting‑inspired colors, sprinkle‑style detailing, and soft textures that transform the classic snack into a huggable furry friend. The collection includes Frosted Animal Cookie Giraffe and Frosted Animal Cookie Camel in Build-A-Bear's beloved make-your-own format, as well as three sweet treat Mini Beans™ featuring a giraffe, camel and lion.
Guests can personalize their Frosted Animal Cookie plush with a wide selection of Build‑A‑Bear clothing and accessories, including a new tutu skirt, dress and party hat, all inspired by the cookie treat. A new Frosted Animal Cookie scent is also available to add to any plush, bringing even more deliciousness to life.
This new collection is ideal for fans drawn to nostalgia‑inspired design, playful pop culture, and joyful moments worth celebrating. The launch supports Build‑A‑Bear's current brand platform, "The Stuff You Love," which celebrates the emotional connections people form through meaningful moments, memories, and personalized experiences.
The Frosted Animal Cookie Collection is available at participating Build-A-Bear locations as well as online at buildabear.com starting today, while supplies last. Stay tuned for more exciting updates and product releases by following @buildabear on Instagram, TikTok and X.
For images and additional information, click here.
About Build-A-Bear
Since its beginning in 1997, Build-A-Bear has evolved to become a beloved multi-generational brand focused on its mission to "add a little more heart to life," where guests of all ages make their own "furry friends" in celebration and commemoration of life moments. Guests create their own stuffed animals by participating in the stuffing, dressing, accessorizing, and naming of their own teddy bears and other plush toys based on the Company's own intellectual property and in conjunction with a variety of best-in-class licenses. The hands-on and interactive nature of our more than 650 company-owned, partner-operated and franchise experience locations around the world, combined with Build-A-Bear's pop-culture appeal, often fosters a lasting and emotional brand connection with consumers and has enabled the Company to expand beyond its retail stores to include e-commerce sales on www.buildabear.com and non-plush branded consumer categories via out-bound licensing agreements with leading manufacturers, as well as the creation of engaging content via Build-A-Bear Entertainment (a subsidiary of Build-A-Bear Workshop, Inc.). The brand's newest communications campaign, "The Stuff You Love," commemorates more than a quarter-century of creating cherished memories worldwide. Build-A-Bear Workshop, Inc. (NYSE: BBW) posted consolidated total revenues of $496.4 million for fiscal 2024. For more information, visit the Investor Relations section of buildabear.com.
SOURCE Build-A-Bear Workshop
2026-03-05 17:056d ago
2026-03-05 12:026d ago
Broadcom Q1: AI Strength Propels Results, Shares Fairly Valued
Analyst’s Disclosure: I/we have no stock, option or similar derivative position in any of the companies mentioned, and no plans to initiate any such positions within the next 72 hours. I wrote this article myself, and it expresses my own opinions. I am not receiving compensation for it (other than from Seeking Alpha). I have no business relationship with any company whose stock is mentioned in this article.
Seeking Alpha's Disclosure: Past performance is no guarantee of future results. No recommendation or advice is being given as to whether any investment is suitable for a particular investor. Any views or opinions expressed above may not reflect those of Seeking Alpha as a whole. Seeking Alpha is not a licensed securities dealer, broker or US investment adviser or investment bank. Our analysts are third party authors that include both professional investors and individual investors who may not be licensed or certified by any institute or regulatory body.
2026-03-05 17:056d ago
2026-03-05 12:046d ago
Gold, silver sell off as USDX rallies, bond yields rise
Jim Wyckoff has spent over 25 years involved with the stock, financial and commodity markets. He was a financial journalist with the FWN newswire service for many years, including stints as a reporter on the rough-and-tumble commodity futures trading floors in Chicago and New York. As a journalist, he has covered every futures market traded in the U.S., at one time or another.
Jim is the proprietor of the "Jim Wyckoff on the Markets" analytical, educational and trading advisory service. Jim also worked as a technical analyst for Dow Jones Newswires and as the senior market analyst with TraderPlanet.com. Jim is also a consultant with the highly respected "Pro Farmer" agricultural advisory service. Jim was also the head equities analyst at CapitalistEdge.com. He received his degree from Iowa State University in Ames, Iowa, where he studied journalism and economics.
Follow Jim daily on Kitco.com as he provides both AM and PM roundups and a daily Technical Special. 1 877 963-NEWS jwyckoff at kitco.com
2026-03-05 16:056d ago
2026-03-05 10:566d ago
Wall Street Analysts See a 467.47% Upside in Silence Therapeutics (SLN): Can the Stock Really Move This High?
Shares of Silence Therapeutics PLC Sponsored ADR (SLN - Free Report) have gained 34.4% over the past four weeks to close the last trading session at $5.78, but there could still be a solid upside left in the stock if short-term price targets of Wall Street analysts are any indication. Going by the price targets, the mean estimate of $32.8 indicates a potential upside of 467.5%.
The mean estimate comprises five short-term price targets with a standard deviation of $26.16. While the lowest estimate of $4.00 indicates a 30.8% decline from the current price level, the most optimistic analyst expects the stock to surge 1197.6% to reach $75.00. It's very important to note the standard deviation here, as it helps understand the variability of the estimates. The smaller the standard deviation, the greater the agreement among analysts.
While the consensus price target is a much-coveted metric for investors, solely banking on this metric to make an investment decision may not be wise at all. That's because the ability and unbiasedness of analysts in setting price targets have long been questionable.
But, for SLN, an impressive average price target is not the only indicator of a potential upside. Strong agreement among analysts about the company's ability to report better earnings than they predicted earlier strengthens this view. While a positive trend in earnings estimate revisions doesn't gauge how much a stock could gain, it has proven to be powerful in predicting an upside.
Price, Consensus and EPS Surprise
Here's What You Should Know About Analysts' Price TargetsAccording to researchers at several universities across the globe, a price target is one of many pieces of information about a stock that misleads investors far more often than it guides. In fact, empirical research shows that price targets set by several analysts, irrespective of the extent of agreement, rarely indicate where the price of a stock could actually be heading.
While Wall Street analysts have deep knowledge of a company's fundamentals and the sensitivity of its business to economic and industry issues, many of them tend to set overly optimistic price targets. Are you wondering why?
They usually do that to drum up interest in shares of companies that their firms either have existing business relationships with or are looking to be associated with. In other words, business incentives of firms covering a stock often result in inflated price targets set by analysts.
However, a tight clustering of price targets, which is represented by a low standard deviation, indicates that analysts have a high degree of agreement about the direction and magnitude of a stock's price movement. While that doesn't necessarily mean the stock will hit the average price target, it could be a good starting point for further research aimed at identifying the potential fundamental driving forces.
That said, while investors should not entirely ignore price targets, making an investment decision solely based on them could lead to disappointing ROI. So, price targets should always be treated with a high degree of skepticism.
Why SLN Could Witness a Solid UpsideThere has been increasing optimism among analysts lately about the company's earnings prospects, as indicated by strong agreement among them in revising EPS estimates higher. And that could be a legitimate reason to expect an upside in the stock. After all, empirical research shows a strong correlation between trends in earnings estimate revisions and near-term stock price movements.
The Zacks Consensus Estimate for the current year has increased 14.5% over the past month, as one estimate has gone higher compared to no negative revision.
Moreover, SLN currently has a Zacks Rank #2 (Buy), which means it is in the top 20% of more than 4,000 stocks that we rank based on four factors related to earnings estimates. Given an impressive externally-audited track record, this is a more conclusive indication of the stock's potential upside in the near term. You can see the complete list of today's Zacks Rank #1 (Strong Buy) stocks here >>>> .
Therefore, while the consensus price target may not be a reliable indicator of how much SLN could gain, the direction of price movement it implies does appear to be a good guide.
2026-03-05 16:056d ago
2026-03-05 10:566d ago
Coca-Cola HBC (CCHGY) Could Find a Support Soon, Here's Why You Should Buy the Stock Now
Shares of Coca-Cola HBC (CCHGY - Free Report) have been struggling lately and have lost 5.8% over the past week. However, a hammer chart pattern was formed in its last trading session, which could mean that the stock found support with bulls being able to counteract the bears. So, it could witness a trend reversal down the road.
While the formation of a hammer pattern is a technical indication of nearing a bottom with potential exhaustion of selling pressure, rising optimism among Wall Street analysts about the future earnings of this company is a solid fundamental factor that enhances the prospects of a trend reversal for the stock.
Understanding Hammer Chart and the Technique to Trade ItThis is one of the popular price patterns in candlestick charting. A minor difference between the opening and closing prices forms a small candle body, and a higher difference between the low of the day and the open or close forms a long lower wick (or vertical line). The length of the lower wick being at least twice the length of the real body, the candle resembles a 'hammer.'
In simple terms, during a downtrend, with bears having absolute control, a stock usually opens lower compared to the previous day's close, and again closes lower. On the day the hammer pattern is formed, maintaining the downtrend, the stock makes a new low. However, after eventually finding support at the low of the day, some amount of buying interest emerges, pushing the stock up to close the session near or slightly above its opening price.
When it occurs at the bottom of a downtrend, this pattern signals that the bears might have lost control over the price. And, the success of bulls in stopping the price from falling further indicates a potential trend reversal.
Hammer candles can occur on any timeframe -- such as one-minute, daily, weekly -- and are utilized by both short-term as well as long-term investors.
Like every technical indicator, the hammer chart pattern has its limitations. Particularly, as the strength of a hammer depends on its placement on the chart, it should always be used in conjunction with other bullish indicators.
Here's What Makes the Trend Reversal More Likely for CCHGYAn upward trend in earnings estimate revisions that CCHGY has been witnessing lately can certainly be considered a bullish indicator on the fundamental side. That's because empirical research shows that trends in earnings estimate revisions are strongly correlated with near-term stock price movements.
The consensus EPS estimate for the current year has increased 2.6% over the last 30 days. This means that the Wall Street analysts covering CCHGY are majorly in agreement about the company's potential to report better earnings than what they predicted earlier.
If this is not enough, you should note that CCHGY currently has a Zacks Rank #2 (Buy), which means it is in the top 20% of more than 4,000 stocks that we rank based on trends in earnings estimate revisions and EPS surprises. And stocks carrying a Zacks Rank #1 or 2 usually outperform the market. You can see the complete list of today's Zacks Rank #1 (Strong Buy) stocks here >>>> .
Moreover, a Zacks Rank of 2 for Coca-Cola HBC is a more conclusive indication of a potential trend reversal, as the Zacks Rank has proven to be an excellent timing indicator that helps investors identify precisely when a company's prospects are beginning to improve.
2026-03-05 16:056d ago
2026-03-05 10:566d ago
Cannabis Stock VRNO Rises 40% in a Year: Time to Buy, Sell or Hold?
Verano stock has surged more than 40% in a year amid U.S. marijuana rescheduling optimism, but revenue headwinds and rising competition may keep investors cautious.
IEX rides strength in the FMT and HST segments, backed by water, pharma and semiconductor demand, while acquisitions like Micro-LAM and Mott expand its tech reach.
2026-03-05 16:056d ago
2026-03-05 10:566d ago
ETFs to Buy as Broadcom Shares Jump 5% After Q1 Earnings Beat
Key Takeaways AVGO jumped nearly 5% after Q1 results as revenues climbed 29% YoY on strong AI semiconductor demand. SOXQ and SOXX offer notable exposure to Broadcom, where the chipmaker ranks among the top holdings. FTEC gives investors diversified exposure to 289 U.S. tech companies, including Broadcom. Shares of Broadcom Inc. (AVGO - Free Report) jumped nearly 5% in the extended trading hours on March 4, 2026, (as cited in CNBC) following the company’s upbeat first-quarter fiscal 2026 results. The company, set to achieve AI revenues from chips in excess of $100 billion in 2027, as mentioned by its CEO on its earnings call, must have impressed investors, which was duly reflected in the chipmaker’s gain in the after-hours trading session.
The company’s fiscal second-quarter revenue guidance also came in better than Wall Street’s $20.53 billion.
Against this backdrop, investors interested in this tech leader, as well as wanting to gain exposure to the AI industry, might want to add AVGO to their portfolio.
However, one must be mindful of the fact that investing in a single stock comes with its share of risk. For instance, in the case of AVGO, these risks come in the form of high customer concentration in its custom AI chip business, with a large portion of revenues coming from a handful of hyperscale clients. This creates high revenue volatility if any major customer shifts to in-house chip development or slows orders.
Therefore, for investors looking to capitalize on AVGO’s better-than-expected revenue growth from its AI business without being fully exposed to the company-specific challenges, a more prudent strategy would be to invest in exchange-traded funds (ETFs) with significant exposure to this chipmaker. This approach should help mitigate risks from customer concentration—such as Broadcom's reliance on a handful of hyperscale clients—or geopolitical factors like recent government scrutiny of its customer Anthropic.
But before diving straight into these ETFs, let us review AVGO’s overall performance in the fiscal first quarter.
A Brief Analysis of AVGO’s Q1 ResultsBroadcom’s first-quarter fiscal 2026 adjusted earnings per share surpassed the Zacks Consensus Estimate by 1% and surged 28.1% year over year. Its revenues rose 29% year over year and beat the consensus mark by a whisker.
The double-digit top-line growth was primarily driven by better-than-expected growth in AI semiconductors.
In its non-AI semiconductor business, the company witnessed flattish year-over-year growth, as revenue growth in enterprise networking, broadband, and server storage was offset by a seasonal decline in wireless.
AVGO ended the fiscal first quarter with an inventory of $3 billion as it continued to secure components to support strong AI demand.
In the interest of its shareholders, it is imperative to mention that Broadcom returned $10.9 billion to its equity holders through dividends and share repurchases.
AVGO expects to generate consolidated revenues of approximately $22 billion in the fiscal second quarter, which represents 47% year-on-year growth. The Zacks Consensus Estimate is pegged at $20.44 billion.
In particular, Broadcom estimates its AI semiconductor business to witness accelerated momentum in the ongoing fiscal quarter, with semiconductor revenues projected to be $14.8 billion. This reflects a surge of 76% year on year.
As far as AVGO’s customers are concerned, the company expects to witness demand worth 1 gigawatt (GW) of TPU compute from Anthropic in 2026, which is estimated to surge in excess of 3 GW next year.
From Google, AVGO expects to witness strong demand for its seventh-generation Ironwood TPU this year.
This fund, with a market value worth $1.02 billion, offers exposure to the 31 largest U.S.-listed securities of companies engaged in the semiconductor business. Of these, AVGO holds the second spot, with a 7.02% share of the fund.
The fund charges 19 basis points (bps) as fees and sports a Zacks ETF Rank #1 (Strong Buy). It traded at a good volume of 1.62 million shares in the last trading session.
VanEck Semiconductor ETF (SMH - Free Report)
This fund, with net assets worth $45.04 billion, provides exposure to 26 companies involved in semiconductor production and equipment. Of these, AVGO holds the third spot, with a 7.04% share of the fund.
The fund charges 35 bps as fees and sports a Zacks ETF Rank #1. It traded at a good volume of 8.74 million shares in the last trading session.
iShares Semiconductor ETF (SOXX - Free Report)
This fund, with net assets worth $21.44 billion, offers exposure to 30 U.S. companies that design, manufacture, and distribute semiconductors. Of these, AVGO holds the fifth spot, with a 5.45% share of the fund.
The fund charges 34 bps as fees and sports a Zacks ETF Rank #1. It traded at a good volume of 10.64 million shares in the last trading session.
Fidelity MSCI Information Technology Index ETF (FTEC - Free Report)
This fund, with net assets worth $15.96 billion, provides exposure to 289 U.S. information technology companies. Of these, AVGO holds the fourth spot, with a 4.27% share of the fund.
The fund charges 8 bps as fees and sports a Zacks ETF Rank 1. It traded at a volume of 0.44 million shares in the last trading session.
2026-03-05 16:056d ago
2026-03-05 10:576d ago
Air Canada's Fleet Transformation Takes Flight as 737 MAX Aircraft Begin Air Canada Rouge Service
First Air Canada Rouge 737 MAX aircraft featuring personal seatback entertainment, Fast, Free Wi-Fi and reclining seats, is now in serviceAir Canada Rouge’s new Vancouver crew base opens today, growing leisure travel options from Western Canada 45 Boeing 737 MAX are expected to transition to Rouge by the end of 2026, supporting Air Canada cabin upgrades across North America MONTRÉAL, March 05, 2026 (GLOBE NEWSWIRE) -- Air Canada today announced the first of its updated Boeing 737 MAX 8 aircraft has entered service at Air Canada Rouge, introducing the industry’s best leisure carrier experience. This marks the latest milestone in Rouge’s comprehensive cabin renewal program, focused on delivering a more comfortable, connected, and consistent onboard experience.
This fleet transition will allow most customers flying Rouge leisure and sun routes across North America and the Caribbean to enjoy upgraded interiors, including personal seatback entertainment, reclining seats and complimentary Fast, Free Wi-Fi sponsored by Bell.
“When customers step onto our aircraft, they should instantly feel a sense of comfort, care, and pride,” said Mark Nasr, Executive Vice President and Chief Operations Officer at Air Canada. “Supported by award-winning service from co-workers across the company, this renewal program is about delivering that feeling consistently, across every flight. Every update is designed with our customers in mind, as we introduce an entirely new Air Canada Rouge product with cutting-edge in-flight entertainment, Fast, Free Wi-Fi, and seats that recline for all customers.”
To support this leisure-focused growth, Air Canada has opened a new Rouge crew base in Vancouver, coinciding with the entry into service of the first Rouge Boeing 737 MAX 8 aircraft. This investment directly supports more sun and leisure flying from Western Canada, such as the recently announced return of winter service from Calgary to Cancun and Puerto Vallarta.
Bringing More Comfort to Air Canada Rouge
Customers flying Rouge will enjoy free wine, beer – including non-alcoholic beer - and Canadian-made premium snacks on all North American and Caribbean flights. The in-flight menus showcase beloved Canadian brands, for an elevated in-flight experience tailored to a range of tastes, including Canadian favourites like MadeGood Morning Bars (on flights before 10 a.m.), TWIGZ pretzels, and Leclerc Célébration cookies.
Improvements to the Rouge fleet focus on what matters most to customers on shorter trips: an upgraded cabin, improved technology, and small details to make the journey easier and more comfortable. The cabins are configured to give customers a choice of 12 Business Class seats, 18 Preferred seats offering extra space, and 147 Standard Economy seats.
Modernizing the North American Fleet
The transformation extends across the entire network. Air Canada’s Airbus A320 and A321 aircraft, currently operated by Rouge, will be retrofitted to Air Canada’s latest design standard, as the airline also prepares for the introduction of new, longer-range Airbus A321XLR aircraft. Upgrades to the customer experience also extend to regional travel, with Air Canada Express aircraft operated by Jazz to be fitted with new cabins and next generation Fast, Free Wi-Fi.
Upcoming Additions to the Fleet
As part of its ongoing fleet modernization program, Air Canada recently announced an order for eight Airbus A350-1000s. This is in addition to the 14 Boeing 787-10 Dreamliners expected to start entering service later this year. Air Canada is also set to welcome in the coming months the first of its 30 Airbus A321XLRs, while continuing to take deliveries of the Canadian-built Airbus A220, with 23 aircraft remaining on its firm order of 65.
These aircraft will enter service with Air Canada’s next generation cabin design and standards, including improved connectivity and in-flight entertainment offerings.
About Air Canada
Air Canada is Canada's largest airline, the country’s flag carrier and a founding member of Star Alliance, the world's most comprehensive air transportation network. Headquartered in Montréal, Air Canada provides scheduled service directly to more than 180 airports in Canada, the United States and Internationally on six continents. It holds a Four-Star ranking from Skytrax. Air Canada’s Aeroplan program is Canada’s premier travel loyalty program, with more than 10 million members worldwide. Members can earn or redeem points on the world’s largest airline partner network of 45 airlines, plus through an extensive range of merchandise, hotel and car rental partners. Through Air Canada Vacations, it offers more travel choices than any other Canadian tour operator to hundreds of destinations worldwide, with a wide selection of hotels, flights, cruises, day tours, and car rentals. Its freight division, Air Canada Cargo, provides air freight lift and connectivity to hundreds of destinations across six continents using Air Canada’s passenger and freighter aircraft. Air Canada’s climate-related ambition includes a long-term aspirational goal of net-zero greenhouse gas emissions by 2050. For additional information, please see Air Canada’s TCFD disclosure. Air Canada shares are publicly traded on the TSX (AC) in Canada and the OTCQX (ACDVF) in the US.
This news release includes forward-looking statements within the meaning of applicable securities laws. Forward-looking statements relate to analyses and other information that are based on forecasts of future results and estimates of amounts not yet determinable. These statements may involve, but are not limited to, comments relating to guidance, strategies, expectations, planned operations or future actions. Forward-looking statements are identified using terms and phrases such as "preliminary"; "anticipate"; "believe"; "could"; "estimate"; "expect"; "intend"; "may"; "plan"; "predict"; "project"; "will"; "would"; and similar terms and phrases, including references to assumptions.
Forward-looking statements, by their nature, are based on assumptions including those described herein and are subject to important risks and uncertainties, which are amplified in the current environment. Forward-looking statements cannot be relied upon due to, among other things, changing external events and general uncertainties of the business of Air Canada. Actual results may differ materially from results indicated in forward-looking statements due to a number of factors, including those discussed below. Factors that may cause results to differ materially from results indicated in forward-looking statements include economic conditions, statements or actions by governments and uncertainty relating to the imposition of (or threats to impose) tariffs on Canadian exports or imports and their resulting impacts on the Canadian, North American and global economies and travel demand, geopolitical conditions such as the military conflicts in the Middle East and between Russia and Ukraine, Air Canada’s ability to successfully achieve or sustain positive net profitability, industry and market conditions and the demand environment, competition, Air Canada’s dependence on technology, cybersecurity risks, interruptions of service, climate change and environmental factors (including weather systems and other natural phenomena and factors arising from anthropogenic sources), Air Canada’s dependence on key suppliers (including government agencies and other stakeholders supporting airport and airline operations), employee and labour relations and costs, Air Canada’s ability to successfully implement appropriate strategic and other important initiatives (including Air Canada’s ability to manage operating costs), energy prices, Air Canada’s ability to pay its indebtedness and maintain or increase liquidity, Air Canada’s dependence on regional and other carriers, Air Canada’s ability to attract and retain required personnel, epidemic diseases, changes in laws, regulatory developments or proceedings, terrorist acts, war, Air Canada’s ability to successfully operate its loyalty program, casualty losses, Air Canada’s dependence on Star Alliance® and joint ventures, Air Canada’s ability to preserve and grow its brand, pending and future litigation and actions by third parties, currency exchange fluctuations, limitations due to restrictive covenants, insurance issues and costs, and pension plan obligations as well as the factors identified in Air Canada’s public disclosure file available at www.sedarplus.ca and, in particular, those identified in section 18 “Risk Factors” of Air Canada’s 2024 MD&A and in section 14 “Risk Factors” of Air Canada’s Third Quarter 2025 MD&A.
Air Canada has and continues to establish targets, make commitments and assess the impact regarding climate change, and related initiatives, plans and proposals that Air Canada and other stakeholders (including government, regulatory and other bodies) are pursuing in relation to climate change and carbon emissions. The achievement of our commitments and targets depends on many factors, including the combined actions of governments, industry, suppliers and other stakeholders and actors, as well as the development and implementation of new technologies. In particular, our 2030 carbon emission-related targets and our related 2050 aspiration are ambitious and heavily dependent on new technologies, renewable energies and the availability of a sufficient supply of sustainable aviation fuels (SAF), which continues to present serious challenges. In addition, Air Canada has incurred, and expects to continue to incur, costs to achieve its goal of net-zero carbon emissions and to comply with environmental sustainability legislation and regulation and other standards and accords. The precise nature of future binding or non-binding legislation, regulation, standards and accords, on which local and international stakeholders are increasingly focusing, cannot be predicted with any degree of certainty, nor can their financial, operational or other impact. There can be no assurance of the extent to which any of our climate goals will be achieved or that any future investments that we make in furtherance of achieving our climate goals will produce the expected results or meet increasing stakeholder environmental, social and governance expectations. Moreover, future events could lead Air Canada to prioritize other nearer-term interests over progressing toward our current climate goals based on business strategy, economic, regulatory and social factors, and potential pressure from investors, activist groups or other stakeholders. If we are unable to meet or properly report on our progress toward achieving our climate change goals and commitments, we could face adverse publicity and reactions from investors, customers, advocacy groups or other stakeholders, which could result in reputational harm or other adverse effects to Air Canada.
The forward-looking statements contained or incorporated by reference in this news release represent Air Canada's expectations as of the date of this news release (or as of the date they are otherwise stated to be made) and are subject to change after such date. However, Air Canada disclaims any intention or obligation to update or revise any forward-looking statements whether because of new information, future events or otherwise, except as required under applicable securities regulations.
A photo accompanying this announcement is available at https://www.globenewswire.com/NewsRoom/AttachmentNg/834ae0d6-36a8-4b20-9919-38d52aff3ea9
2026-03-05 16:056d ago
2026-03-05 10:596d ago
Wix.com: No AI Apocalypse In Sight, Only Tailwinds (Upgrade)
Analyst’s Disclosure: I/we have a beneficial long position in the shares of WIX either through stock ownership, options, or other derivatives. I wrote this article myself, and it expresses my own opinions. I am not receiving compensation for it (other than from Seeking Alpha). I have no business relationship with any company whose stock is mentioned in this article.
Seeking Alpha's Disclosure: Past performance is no guarantee of future results. No recommendation or advice is being given as to whether any investment is suitable for a particular investor. Any views or opinions expressed above may not reflect those of Seeking Alpha as a whole. Seeking Alpha is not a licensed securities dealer, broker or US investment adviser or investment bank. Our analysts are third party authors that include both professional investors and individual investors who may not be licensed or certified by any institute or regulatory body.
2026-03-05 16:056d ago
2026-03-05 10:596d ago
Cloud stocks jump, head for best day in nearly a year despite broad market declines
Cloud stocks were a rare bright spot amid Thursday's market drop.
The WisdomTree Cloud Computing Fund (WCLD) gained 4.5%, putting the exchange-traded fund on track for its best day since April 24, when it jumped 4.7%.
Leading the WCLD fund higher was an 8.8% pop in Okta and Wix.com, and a roughly 7% gain in shares of MongoDB and Intapp. Sailpoint, an identity security tech provider for cloud enterprises, rose 6.5%.
The rally in Okta comes after the identity security provider reported fourth-quarter results Wednesday evening that exceeded Wall Street's estimates. To be sure, the company, which has benefitted agentic artificial intelligence tools and the rise of related security needs, gave weak guidance for its first quarter.
Thursday's pop puts Okta on track for its best day since April 9, when it gained 11.3%. Okta remains beaten-down amid the software crush, however, as the stock is down 9.8% year to date.
Cloud stocks remain under pressure for 2026 despite the day's gains. The fund is down about 16.2% year to date. Shares of cloud companies have dropped this year as concerns about artificial intelligence disruption to incumbent software stocks plagued the group.
SALT LAKE CITY, UTAH / ACCESS Newswire / March 5, 2026 / FatPipe, Inc. (NASDAQ:FATN), a pioneer in enterprise-class, application-aware, secure software-defined wide area network ("SD-WAN") solutions that provide high levels of reliability, security, and optimization for Wide Area Networks (WANs) and single-stack cybersecurity solutions, today announced it published a letter from its CEO, Dr. Ragula Bhaskar.
Dear Shareholders,
Greetings as we enter the early spring season.
At FatPipe, we continue to execute on our plan to increase sales by expanding our sales team, activating signed partners, and onboarding new partners. Our strategy remains unchanged. Sanch, my co-founder and CTO, and I remain laser focused on driving sales growth.
We are very excited that the Independent research firm Zacks Small Cap Research initiated coverage of FatPipe with an initial target price of $5 per share (Zacks Small Cap Research - FATN: Initiation - FatPipe's Greatly Increased Salesforce Should Accelerate Growth in FY 2027) We are also very excited to continue to receive the awards for our innovation and product solutions (e.g., Info-Tech and TMCnet Zero Trust Security Excellence). Our world class support and product innovation will continue to drive increased revenue in the current quarter and beyond.
As we are presented with opportunities to accelerate our growth, we will evaluate them on a case-by-case basis to determine how they can strengthen our product portfolio, expand our market share, and, where appropriate, use prudent leverage to enhance shareholder value.
We look forward to providing you with more information in our upcoming year-end earnings call.
Thank you for your continued support and confidence in FatPipe as we build on our leadership in SD-WAN and cybersecurity innovation.
Sincerely,
Dr. Ragula Bhaskar
Chief Executive Officer
FatPipe, Inc. (NASDAQ:FATN)
About FatPipe, Inc.
FatPipe pioneered the concept of software-defined wide area networking (SD-WAN) and hybrid WANs that eliminated the need for cooperation from ISPs and allow companies and service providers to control multi-link network traffic worldwide. FatPipe has now pioneered cost-effective, advanced single-stack cybersecurity for on-premise deployments that significantly improve network and cybersecurity for SMBs.
For more information, please visit www.fatpipeinc.com.
Follow us on X @FatPipe_Inc.
Forward-Looking Statements
Certain statements contained in this press release, may constitute forward-looking statements within the meaning of the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. Such forward-looking statements can generally be identified by our use of forward-looking terminology such as "may," "will," "expect," "intend," "anticipate," "estimate," "believe," "continue," or other similar words. Readers are cautioned not to place undue reliance on these forward-looking statements, which are based on management's current expectations and are inherently subject to various risks, uncertainties, assumptions, or changes in circumstances that are difficult to predict or quantify. These risks and uncertainties include, but are not limited to, those described in FatPipe's filings with the U.S. Securities and Exchange Commission. Except as required by law, FatPipe expressly disclaims a duty to provide updates to forward-looking statements, whether as a result of new information, future events or other occurrences.
Neinor Homes successfully completes acquisition of AEDAS, reaching c.97% ownership and consolidates Spanish National Champion
Madrid, 5 March, 2026 – Neinor Homes (“Neinor”), Spain’s leading listed residential developer, announces the successful completion of the acquisition of AEDAS Homes (“AEDAS”), having increased its ownership to 96.83% through the mandatory tender offer.
In December 2025, Neinor acquired a 79.20% controlling stake in AEDAS through the voluntary tender offer, securing the support of its main shareholder, Castlelake. In February 2026, Neinor formally assumed control of AEDAS’s Board of Directors.
The mandatory tender offer has now been completed with an acceptance of 17.63%, increasing Neinor’s total ownership to 96.83%. This outcome reflects the strong support of AEDAS shareholders, initially Castlelake and subsequently a substantial majority of minority investors.
In total, Neinor has invested €923mn to acquire its 96.83% stake in AEDAS, at an average price of €21.82 per share, representing a discount of approximately 30% to the appraised value at the time of the transaction announcement.
Borja García-Egotxeaga, CEO of Neinor Homes, commented: “With this transaction completed, we have created Spain’s national residential champion. We delivered exactly what we set out to do — on time and with full control. The focus now is clear: disciplined execution and value creation.”
Jordi Argemí, Deputy CEO and CFO of Neinor Homes, added: “We are very pleased to have taken full control of AEDAS. This level of acceptance reflects the strength of the transaction and the support from a vast majority of shareholders. Our priority now is to execute the business plan and unlock the company’s full value.”
* For the full regulatory announcement please refer to Neinor’s webpage (https://www.neinorhomes.com/en/corporate/investors/market-notifications/other-relevant-information/)
Wall Street expects a year-over-year decline in earnings on higher revenues when Ulta Beauty (ULTA - Free Report) reports results for the quarter ended January 2026. While this widely-known consensus outlook is important in gauging the company's earnings picture, a powerful factor that could impact its near-term stock price is how the actual results compare to these estimates.
The earnings report, which is expected to be released on March 12, might help the stock move higher if these key numbers are better than expectations. On the other hand, if they miss, the stock may move lower.
While the sustainability of the immediate price change and future earnings expectations will mostly depend on management's discussion of business conditions on the earnings call, it's worth handicapping the probability of a positive EPS surprise.
Zacks Consensus EstimateThis beauty products retailer is expected to post quarterly earnings of $7.98 per share in its upcoming report, which represents a year-over-year change of -5.7%.
Revenues are expected to be $3.83 billion, up 9.9% from the year-ago quarter.
Estimate Revisions TrendThe consensus EPS estimate for the quarter has been revised 0.33% lower over the last 30 days to the current level. This is essentially a reflection of how the covering analysts have collectively reassessed their initial estimates over this period.
Investors should keep in mind that an aggregate change may not always reflect the direction of estimate revisions by each of the covering analysts.
Price, Consensus and EPS Surprise
Earnings WhisperEstimate revisions ahead of a company's earnings release offer clues to the business conditions for the period whose results are coming out. Our proprietary surprise prediction model -- the Zacks Earnings ESP (Expected Surprise Prediction) -- has this insight at its core.
The Zacks Earnings ESP compares the Most Accurate Estimate to the Zacks Consensus Estimate for the quarter; the Most Accurate Estimate is a more recent version of the Zacks Consensus EPS estimate. The idea here is that analysts revising their estimates right before an earnings release have the latest information, which could potentially be more accurate than what they and others contributing to the consensus had predicted earlier.
Thus, a positive or negative Earnings ESP reading theoretically indicates the likely deviation of the actual earnings from the consensus estimate. However, the model's predictive power is significant for positive ESP readings only.
A positive Earnings ESP is a strong predictor of an earnings beat, particularly when combined with a Zacks Rank #1 (Strong Buy), 2 (Buy) or 3 (Hold). Our research shows that stocks with this combination produce a positive surprise nearly 70% of the time, and a solid Zacks Rank actually increases the predictive power of Earnings ESP.
Please note that a negative Earnings ESP reading is not indicative of an earnings miss. Our research shows that it is difficult to predict an earnings beat with any degree of confidence for stocks with negative Earnings ESP readings and/or Zacks Rank of 4 (Sell) or 5 (Strong Sell).
How Have the Numbers Shaped Up for Ulta?For Ulta, the Most Accurate Estimate is higher than the Zacks Consensus Estimate, suggesting that analysts have recently become bullish on the company's earnings prospects. This has resulted in an Earnings ESP of +11.98%.
On the other hand, the stock currently carries a Zacks Rank of #3.
So, this combination indicates that Ulta will most likely beat the consensus EPS estimate.
Does Earnings Surprise History Hold Any Clue?Analysts often consider to what extent a company has been able to match consensus estimates in the past while calculating their estimates for its future earnings. So, it's worth taking a look at the surprise history for gauging its influence on the upcoming number.
For the last reported quarter, it was expected that Ulta would post earnings of $4.56 per share when it actually produced earnings of $5.14, delivering a surprise of +12.72%.
Over the last four quarters, the company has beaten consensus EPS estimates four times.
Bottom LineAn earnings beat or miss may not be the sole basis for a stock moving higher or lower. Many stocks end up losing ground despite an earnings beat due to other factors that disappoint investors. Similarly, unforeseen catalysts help a number of stocks gain despite an earnings miss.
That said, betting on stocks that are expected to beat earnings expectations does increase the odds of success. This is why it's worth checking a company's Earnings ESP and Zacks Rank ahead of its quarterly release. Make sure to utilize our Earnings ESP Filter to uncover the best stocks to buy or sell before they've reported.
Ulta appears a compelling earnings-beat candidate. However, investors should pay attention to other factors too for betting on this stock or staying away from it ahead of its earnings release.
Stay on top of upcoming earnings announcements with the Zacks Earnings Calendar.
2026-03-05 16:056d ago
2026-03-05 11:016d ago
Rubrik, Inc. (RBRK) Expected to Beat Earnings Estimates: Should You Buy?
Rubrik, Inc. (RBRK - Free Report) is expected to deliver a year-over-year increase in earnings on higher revenues when it reports results for the quarter ended January 2026. This widely-known consensus outlook gives a good sense of the company's earnings picture, but how the actual results compare to these estimates is a powerful factor that could impact its near-term stock price.
The stock might move higher if these key numbers top expectations in the upcoming earnings report, which is expected to be released on March 12. On the other hand, if they miss, the stock may move lower.
While the sustainability of the immediate price change and future earnings expectations will mostly depend on management's discussion of business conditions on the earnings call, it's worth handicapping the probability of a positive EPS surprise.
Zacks Consensus EstimateThis company is expected to post quarterly loss of $0.11 per share in its upcoming report, which represents a year-over-year change of +38.9%.
Revenues are expected to be $342.11 million, up 32.6% from the year-ago quarter.
Estimate Revisions TrendThe consensus EPS estimate for the quarter has been revised 0.78% higher over the last 30 days to the current level. This is essentially a reflection of how the covering analysts have collectively reassessed their initial estimates over this period.
Investors should keep in mind that an aggregate change may not always reflect the direction of estimate revisions by each of the covering analysts.
Price, Consensus and EPS Surprise
Earnings WhisperEstimate revisions ahead of a company's earnings release offer clues to the business conditions for the period whose results are coming out. This insight is at the core of our proprietary surprise prediction model -- the Zacks Earnings ESP (Expected Surprise Prediction).
The Zacks Earnings ESP compares the Most Accurate Estimate to the Zacks Consensus Estimate for the quarter; the Most Accurate Estimate is a more recent version of the Zacks Consensus EPS estimate. The idea here is that analysts revising their estimates right before an earnings release have the latest information, which could potentially be more accurate than what they and others contributing to the consensus had predicted earlier.
Thus, a positive or negative Earnings ESP reading theoretically indicates the likely deviation of the actual earnings from the consensus estimate. However, the model's predictive power is significant for positive ESP readings only.
A positive Earnings ESP is a strong predictor of an earnings beat, particularly when combined with a Zacks Rank #1 (Strong Buy), 2 (Buy) or 3 (Hold). Our research shows that stocks with this combination produce a positive surprise nearly 70% of the time, and a solid Zacks Rank actually increases the predictive power of Earnings ESP.
Please note that a negative Earnings ESP reading is not indicative of an earnings miss. Our research shows that it is difficult to predict an earnings beat with any degree of confidence for stocks with negative Earnings ESP readings and/or Zacks Rank of 4 (Sell) or 5 (Strong Sell).
How Have the Numbers Shaped Up for Rubrik, Inc.?For Rubrik, Inc., the Most Accurate Estimate is higher than the Zacks Consensus Estimate, suggesting that analysts have recently become bullish on the company's earnings prospects. This has resulted in an Earnings ESP of +10.00%.
On the other hand, the stock currently carries a Zacks Rank of #3.
So, this combination indicates that Rubrik, Inc. will most likely beat the consensus EPS estimate.
Does Earnings Surprise History Hold Any Clue?While calculating estimates for a company's future earnings, analysts often consider to what extent it has been able to match past consensus estimates. So, it's worth taking a look at the surprise history for gauging its influence on the upcoming number.
For the last reported quarter, it was expected that Rubrik, Inc. would post a loss of$0.17 per share when it actually produced earnings of $0.10, delivering a surprise of +158.82%.
Over the last four quarters, the company has beaten consensus EPS estimates four times.
Bottom LineAn earnings beat or miss may not be the sole basis for a stock moving higher or lower. Many stocks end up losing ground despite an earnings beat due to other factors that disappoint investors. Similarly, unforeseen catalysts help a number of stocks gain despite an earnings miss.
That said, betting on stocks that are expected to beat earnings expectations does increase the odds of success. This is why it's worth checking a company's Earnings ESP and Zacks Rank ahead of its quarterly release. Make sure to utilize our Earnings ESP Filter to uncover the best stocks to buy or sell before they've reported.
Rubrik, Inc. appears a compelling earnings-beat candidate. However, investors should pay attention to other factors too for betting on this stock or staying away from it ahead of its earnings release.
Expected Results of an Industry PlayerAmong the stocks in the Zacks Internet - Software industry, CI&T Inc. (CINT - Free Report) , is soon expected to post earnings of $0.1 per share for the quarter ended January 2026. This estimate indicates a year-over-year change of +25%. This quarter's revenue is expected to be $131.96 million, up 17.5% from the year-ago quarter.
Over the last 30 days, the consensus EPS estimate for CI&T has been revised 2% up to the current level. Nevertheless, the company now has an Earnings ESP of +5.26%, reflecting a higher Most Accurate Estimate.
When combined with a Zacks Rank of #3 (Hold), this Earnings ESP indicates that CI&T will most likely beat the consensus EPS estimate. Over the last four quarters, the company surpassed EPS estimates just once.
Stay on top of upcoming earnings announcements with the Zacks Earnings Calendar.
2026-03-05 16:056d ago
2026-03-05 11:016d ago
ServiceTitan Inc. (TTAN) Reports Next Week: Wall Street Expects Earnings Growth
The market expects ServiceTitan Inc. (TTAN - Free Report) to deliver a year-over-year increase in earnings on higher revenues when it reports results for the quarter ended January 2026. This widely-known consensus outlook is important in assessing the company's earnings picture, but a powerful factor that might influence its near-term stock price is how the actual results compare to these estimates.
The stock might move higher if these key numbers top expectations in the upcoming earnings report, which is expected to be released on March 12. On the other hand, if they miss, the stock may move lower.
While the sustainability of the immediate price change and future earnings expectations will mostly depend on management's discussion of business conditions on the earnings call, it's worth handicapping the probability of a positive EPS surprise.
Zacks Consensus EstimateThis company is expected to post quarterly earnings of $0.18 per share in its upcoming report, which represents a year-over-year change of +50%.
Revenues are expected to be $245.38 million, up 17.3% from the year-ago quarter.
Estimate Revisions TrendThe consensus EPS estimate for the quarter has remained unchanged over the last 30 days. This is essentially a reflection of how the covering analysts have collectively reassessed their initial estimates over this period.
Investors should keep in mind that an aggregate change may not always reflect the direction of estimate revisions by each of the covering analysts.
Price, Consensus and EPS Surprise
Earnings WhisperEstimate revisions ahead of a company's earnings release offer clues to the business conditions for the period whose results are coming out. This insight is at the core of our proprietary surprise prediction model -- the Zacks Earnings ESP (Expected Surprise Prediction).
The Zacks Earnings ESP compares the Most Accurate Estimate to the Zacks Consensus Estimate for the quarter; the Most Accurate Estimate is a more recent version of the Zacks Consensus EPS estimate. The idea here is that analysts revising their estimates right before an earnings release have the latest information, which could potentially be more accurate than what they and others contributing to the consensus had predicted earlier.
Thus, a positive or negative Earnings ESP reading theoretically indicates the likely deviation of the actual earnings from the consensus estimate. However, the model's predictive power is significant for positive ESP readings only.
A positive Earnings ESP is a strong predictor of an earnings beat, particularly when combined with a Zacks Rank #1 (Strong Buy), 2 (Buy) or 3 (Hold). Our research shows that stocks with this combination produce a positive surprise nearly 70% of the time, and a solid Zacks Rank actually increases the predictive power of Earnings ESP.
Please note that a negative Earnings ESP reading is not indicative of an earnings miss. Our research shows that it is difficult to predict an earnings beat with any degree of confidence for stocks with negative Earnings ESP readings and/or Zacks Rank of 4 (Sell) or 5 (Strong Sell).
How Have the Numbers Shaped Up for ServiceTitan Inc.?For ServiceTitan Inc., the Most Accurate Estimate is higher than the Zacks Consensus Estimate, suggesting that analysts have recently become bullish on the company's earnings prospects. This has resulted in an Earnings ESP of +13.21%.
On the other hand, the stock currently carries a Zacks Rank of #2.
So, this combination indicates that ServiceTitan Inc. will most likely beat the consensus EPS estimate.
Does Earnings Surprise History Hold Any Clue?While calculating estimates for a company's future earnings, analysts often consider to what extent it has been able to match past consensus estimates. So, it's worth taking a look at the surprise history for gauging its influence on the upcoming number.
For the last reported quarter, it was expected that ServiceTitan Inc. would post earnings of $0.15 per share when it actually produced earnings of $0.24, delivering a surprise of +60.00%.
Over the last four quarters, the company has beaten consensus EPS estimates four times.
Bottom LineAn earnings beat or miss may not be the sole basis for a stock moving higher or lower. Many stocks end up losing ground despite an earnings beat due to other factors that disappoint investors. Similarly, unforeseen catalysts help a number of stocks gain despite an earnings miss.
That said, betting on stocks that are expected to beat earnings expectations does increase the odds of success. This is why it's worth checking a company's Earnings ESP and Zacks Rank ahead of its quarterly release. Make sure to utilize our Earnings ESP Filter to uncover the best stocks to buy or sell before they've reported.
ServiceTitan Inc. appears a compelling earnings-beat candidate. However, investors should pay attention to other factors too for betting on this stock or staying away from it ahead of its earnings release.
Stay on top of upcoming earnings announcements with the Zacks Earnings Calendar.
2026-03-05 16:056d ago
2026-03-05 11:016d ago
Sunrise Realty Trust, Inc. (SUNS) Earnings Expected to Grow: What to Know Ahead of Next Week's Release
The market expects Sunrise Realty Trust, Inc. (SUNS - Free Report) to deliver a year-over-year increase in earnings on higher revenues when it reports results for the quarter ended December 2025. This widely-known consensus outlook is important in assessing the company's earnings picture, but a powerful factor that might influence its near-term stock price is how the actual results compare to these estimates.
The stock might move higher if these key numbers top expectations in the upcoming earnings report, which is expected to be released on March 12. On the other hand, if they miss, the stock may move lower.
While management's discussion of business conditions on the earnings call will mostly determine the sustainability of the immediate price change and future earnings expectations, it's worth having a handicapping insight into the odds of a positive EPS surprise.
Zacks Consensus EstimateThis company is expected to post quarterly earnings of $0.31 per share in its upcoming report, which represents a year-over-year change of +3.3%.
Revenues are expected to be $6.11 million, up 77.6% from the year-ago quarter.
Estimate Revisions TrendThe consensus EPS estimate for the quarter has remained unchanged over the last 30 days. This is essentially a reflection of how the covering analysts have collectively reassessed their initial estimates over this period.
Investors should keep in mind that the direction of estimate revisions by each of the covering analysts may not always get reflected in the aggregate change.
Price, Consensus and EPS Surprise
Earnings WhisperEstimate revisions ahead of a company's earnings release offer clues to the business conditions for the period whose results are coming out. This insight is at the core of our proprietary surprise prediction model -- the Zacks Earnings ESP (Expected Surprise Prediction).
The Zacks Earnings ESP compares the Most Accurate Estimate to the Zacks Consensus Estimate for the quarter; the Most Accurate Estimate is a more recent version of the Zacks Consensus EPS estimate. The idea here is that analysts revising their estimates right before an earnings release have the latest information, which could potentially be more accurate than what they and others contributing to the consensus had predicted earlier.
Thus, a positive or negative Earnings ESP reading theoretically indicates the likely deviation of the actual earnings from the consensus estimate. However, the model's predictive power is significant for positive ESP readings only.
A positive Earnings ESP is a strong predictor of an earnings beat, particularly when combined with a Zacks Rank #1 (Strong Buy), 2 (Buy) or 3 (Hold). Our research shows that stocks with this combination produce a positive surprise nearly 70% of the time, and a solid Zacks Rank actually increases the predictive power of Earnings ESP.
Please note that a negative Earnings ESP reading is not indicative of an earnings miss. Our research shows that it is difficult to predict an earnings beat with any degree of confidence for stocks with negative Earnings ESP readings and/or Zacks Rank of 4 (Sell) or 5 (Strong Sell).
How Have the Numbers Shaped Up for Sunrise Realty Trust, Inc.?For Sunrise Realty Trust, Inc., the Most Accurate Estimate is lower than the Zacks Consensus Estimate, suggesting that analysts have recently become bearish on the company's earnings prospects. This has resulted in an Earnings ESP of -1.64%.
On the other hand, the stock currently carries a Zacks Rank of #3.
So, this combination makes it difficult to conclusively predict that Sunrise Realty Trust, Inc. will beat the consensus EPS estimate.
Does Earnings Surprise History Hold Any Clue?Analysts often consider to what extent a company has been able to match consensus estimates in the past while calculating their estimates for its future earnings. So, it's worth taking a look at the surprise history for gauging its influence on the upcoming number.
For the last reported quarter, it was expected that Sunrise Realty Trust, Inc. would post earnings of $0.31 per share when it actually produced earnings of $0.31, delivering no surprise.
Over the last four quarters, the company has beaten consensus EPS estimates two times.
Bottom LineAn earnings beat or miss may not be the sole basis for a stock moving higher or lower. Many stocks end up losing ground despite an earnings beat due to other factors that disappoint investors. Similarly, unforeseen catalysts help a number of stocks gain despite an earnings miss.
That said, betting on stocks that are expected to beat earnings expectations does increase the odds of success. This is why it's worth checking a company's Earnings ESP and Zacks Rank ahead of its quarterly release. Make sure to utilize our Earnings ESP Filter to uncover the best stocks to buy or sell before they've reported.
Sunrise Realty Trust, Inc. doesn't appear a compelling earnings-beat candidate. However, investors should pay attention to other factors too for betting on this stock or staying away from it ahead of its earnings release.
Stay on top of upcoming earnings announcements with the Zacks Earnings Calendar.
2026-03-05 16:056d ago
2026-03-05 11:016d ago
Runway Growth Finance Corp. (RWAY) Expected to Beat Earnings Estimates: What to Know Ahead of Q4 Release
Wall Street expects a year-over-year decline in earnings on lower revenues when Runway Growth Finance Corp. (RWAY - Free Report) reports results for the quarter ended December 2025. While this widely-known consensus outlook is important in gauging the company's earnings picture, a powerful factor that could impact its near-term stock price is how the actual results compare to these estimates.
The earnings report, which is expected to be released on March 12, might help the stock move higher if these key numbers are better than expectations. On the other hand, if they miss, the stock may move lower.
While the sustainability of the immediate price change and future earnings expectations will mostly depend on management's discussion of business conditions on the earnings call, it's worth handicapping the probability of a positive EPS surprise.
Zacks Consensus EstimateThis company is expected to post quarterly earnings of $0.36 per share in its upcoming report, which represents a year-over-year change of -7.7%.
Revenues are expected to be $32.19 million, down 4.7% from the year-ago quarter.
Estimate Revisions TrendThe consensus EPS estimate for the quarter has been revised 0.95% higher over the last 30 days to the current level. This is essentially a reflection of how the covering analysts have collectively reassessed their initial estimates over this period.
Investors should keep in mind that an aggregate change may not always reflect the direction of estimate revisions by each of the covering analysts.
Price, Consensus and EPS Surprise
Earnings WhisperEstimate revisions ahead of a company's earnings release offer clues to the business conditions for the period whose results are coming out. Our proprietary surprise prediction model -- the Zacks Earnings ESP (Expected Surprise Prediction) -- has this insight at its core.
The Zacks Earnings ESP compares the Most Accurate Estimate to the Zacks Consensus Estimate for the quarter; the Most Accurate Estimate is a more recent version of the Zacks Consensus EPS estimate. The idea here is that analysts revising their estimates right before an earnings release have the latest information, which could potentially be more accurate than what they and others contributing to the consensus had predicted earlier.
Thus, a positive or negative Earnings ESP reading theoretically indicates the likely deviation of the actual earnings from the consensus estimate. However, the model's predictive power is significant for positive ESP readings only.
A positive Earnings ESP is a strong predictor of an earnings beat, particularly when combined with a Zacks Rank #1 (Strong Buy), 2 (Buy) or 3 (Hold). Our research shows that stocks with this combination produce a positive surprise nearly 70% of the time, and a solid Zacks Rank actually increases the predictive power of Earnings ESP.
Please note that a negative Earnings ESP reading is not indicative of an earnings miss. Our research shows that it is difficult to predict an earnings beat with any degree of confidence for stocks with negative Earnings ESP readings and/or Zacks Rank of 4 (Sell) or 5 (Strong Sell).
How Have the Numbers Shaped Up for Runway Growth Finance Corp.?For Runway Growth Finance Corp., the Most Accurate Estimate is higher than the Zacks Consensus Estimate, suggesting that analysts have recently become bullish on the company's earnings prospects. This has resulted in an Earnings ESP of +0.70%.
On the other hand, the stock currently carries a Zacks Rank of #3.
So, this combination indicates that Runway Growth Finance Corp. will most likely beat the consensus EPS estimate.
Does Earnings Surprise History Hold Any Clue?While calculating estimates for a company's future earnings, analysts often consider to what extent it has been able to match past consensus estimates. So, it's worth taking a look at the surprise history for gauging its influence on the upcoming number.
For the last reported quarter, it was expected that Runway Growth Finance Corp. would post earnings of $0.38 per share when it actually produced earnings of $0.43, delivering a surprise of +13.16%.
Over the last four quarters, the company has beaten consensus EPS estimates two times.
Bottom LineAn earnings beat or miss may not be the sole basis for a stock moving higher or lower. Many stocks end up losing ground despite an earnings beat due to other factors that disappoint investors. Similarly, unforeseen catalysts help a number of stocks gain despite an earnings miss.
That said, betting on stocks that are expected to beat earnings expectations does increase the odds of success. This is why it's worth checking a company's Earnings ESP and Zacks Rank ahead of its quarterly release. Make sure to utilize our Earnings ESP Filter to uncover the best stocks to buy or sell before they've reported.
Runway Growth Finance Corp. appears a compelling earnings-beat candidate. However, investors should pay attention to other factors too for betting on this stock or staying away from it ahead of its earnings release.
Stay on top of upcoming earnings announcements with the Zacks Earnings Calendar.
2026-03-05 16:056d ago
2026-03-05 11:016d ago
Earnings Preview: Gossamer Bio (GOSS) Q4 Earnings Expected to Decline
The market expects Gossamer Bio (GOSS - Free Report) to deliver a year-over-year decline in earnings on lower revenues when it reports results for the quarter ended December 2025. This widely-known consensus outlook is important in assessing the company's earnings picture, but a powerful factor that might influence its near-term stock price is how the actual results compare to these estimates.
The earnings report might help the stock move higher if these key numbers are better than expectations. On the other hand, if they miss, the stock may move lower.
While management's discussion of business conditions on the earnings call will mostly determine the sustainability of the immediate price change and future earnings expectations, it's worth having a handicapping insight into the odds of a positive EPS surprise.
Zacks Consensus EstimateThis biopharmaceutical company is expected to post quarterly loss of $0.19 per share in its upcoming report, which represents a year-over-year change of -26.7%.
Revenues are expected to be $7.6 million, down 19% from the year-ago quarter.
Estimate Revisions TrendThe consensus EPS estimate for the quarter has been revised 1.33% lower over the last 30 days to the current level. This is essentially a reflection of how the covering analysts have collectively reassessed their initial estimates over this period.
Investors should keep in mind that an aggregate change may not always reflect the direction of estimate revisions by each of the covering analysts.
Price, Consensus and EPS Surprise
Earnings WhisperEstimate revisions ahead of a company's earnings release offer clues to the business conditions for the period whose results are coming out. Our proprietary surprise prediction model -- the Zacks Earnings ESP (Expected Surprise Prediction) -- has this insight at its core.
The Zacks Earnings ESP compares the Most Accurate Estimate to the Zacks Consensus Estimate for the quarter; the Most Accurate Estimate is a more recent version of the Zacks Consensus EPS estimate. The idea here is that analysts revising their estimates right before an earnings release have the latest information, which could potentially be more accurate than what they and others contributing to the consensus had predicted earlier.
Thus, a positive or negative Earnings ESP reading theoretically indicates the likely deviation of the actual earnings from the consensus estimate. However, the model's predictive power is significant for positive ESP readings only.
A positive Earnings ESP is a strong predictor of an earnings beat, particularly when combined with a Zacks Rank #1 (Strong Buy), 2 (Buy) or 3 (Hold). Our research shows that stocks with this combination produce a positive surprise nearly 70% of the time, and a solid Zacks Rank actually increases the predictive power of Earnings ESP.
Please note that a negative Earnings ESP reading is not indicative of an earnings miss. Our research shows that it is difficult to predict an earnings beat with any degree of confidence for stocks with negative Earnings ESP readings and/or Zacks Rank of 4 (Sell) or 5 (Strong Sell).
How Have the Numbers Shaped Up for Gossamer Bio?For Gossamer Bio, the Most Accurate Estimate is lower than the Zacks Consensus Estimate, suggesting that analysts have recently become bearish on the company's earnings prospects. This has resulted in an Earnings ESP of -30.21%.
On the other hand, the stock currently carries a Zacks Rank of #2.
So, this combination makes it difficult to conclusively predict that Gossamer Bio will beat the consensus EPS estimate.
Does Earnings Surprise History Hold Any Clue?Analysts often consider to what extent a company has been able to match consensus estimates in the past while calculating their estimates for its future earnings. So, it's worth taking a look at the surprise history for gauging its influence on the upcoming number.
For the last reported quarter, it was expected that Gossamer Bio would post a loss of$0.19 per share when it actually produced a loss of -$0.21, delivering a surprise of -10.53%.
Over the last four quarters, the company has beaten consensus EPS estimates three times.
Bottom LineAn earnings beat or miss may not be the sole basis for a stock moving higher or lower. Many stocks end up losing ground despite an earnings beat due to other factors that disappoint investors. Similarly, unforeseen catalysts help a number of stocks gain despite an earnings miss.
That said, betting on stocks that are expected to beat earnings expectations does increase the odds of success. This is why it's worth checking a company's Earnings ESP and Zacks Rank ahead of its quarterly release. Make sure to utilize our Earnings ESP Filter to uncover the best stocks to buy or sell before they've reported.
Gossamer Bio doesn't appear a compelling earnings-beat candidate. However, investors should pay attention to other factors too for betting on this stock or staying away from it ahead of its earnings release.
Expected Results of an Industry PlayerAnother stock from the Zacks Medical - Biomedical and Genetics industry, Adherex Technologies Inc. (FENC - Free Report) , is soon expected to post earnings of $0.03 per share for the quarter ended December 2025. This estimate indicates a year-over-year change of +150%. Revenues for the quarter are expected to be $14.97 million, up 88.8% from the year-ago quarter.
The consensus EPS estimate for Adherex Technologies has been revised 403.6% higher over the last 30 days to the current level. However, a higher Most Accurate Estimate has resulted in an Earnings ESP of +140.00%.
This Earnings ESP, combined with its Zacks Rank #3 (Hold), suggests that Adherex Technologies will most likely beat the consensus EPS estimate. Over the last four quarters, the company surpassed consensus EPS estimates two times.
Stay on top of upcoming earnings announcements with the Zacks Earnings Calendar.
2026-03-05 16:056d ago
2026-03-05 11:016d ago
Analysts Estimate Nektar Therapeutics (NKTR) to Report a Decline in Earnings: What to Look Out for
Nektar Therapeutics (NKTR - Free Report) is expected to deliver a year-over-year decline in earnings on lower revenues when it reports results for the quarter ended December 2025. This widely-known consensus outlook gives a good sense of the company's earnings picture, but how the actual results compare to these estimates is a powerful factor that could impact its near-term stock price.
The earnings report, which is expected to be released on March 12, might help the stock move higher if these key numbers are better than expectations. On the other hand, if they miss, the stock may move lower.
While the sustainability of the immediate price change and future earnings expectations will mostly depend on management's discussion of business conditions on the earnings call, it's worth handicapping the probability of a positive EPS surprise.
Zacks Consensus EstimateThis biopharmaceutical company is expected to post quarterly loss of $2.76 per share in its upcoming report, which represents a year-over-year change of -22.7%.
Revenues are expected to be $9.54 million, down 67.3% from the year-ago quarter.
Estimate Revisions TrendThe consensus EPS estimate for the quarter has been revised 7.57% higher over the last 30 days to the current level. This is essentially a reflection of how the covering analysts have collectively reassessed their initial estimates over this period.
Investors should keep in mind that an aggregate change may not always reflect the direction of estimate revisions by each of the covering analysts.
Price, Consensus and EPS Surprise
Earnings WhisperEstimate revisions ahead of a company's earnings release offer clues to the business conditions for the period whose results are coming out. This insight is at the core of our proprietary surprise prediction model -- the Zacks Earnings ESP (Expected Surprise Prediction).
The Zacks Earnings ESP compares the Most Accurate Estimate to the Zacks Consensus Estimate for the quarter; the Most Accurate Estimate is a more recent version of the Zacks Consensus EPS estimate. The idea here is that analysts revising their estimates right before an earnings release have the latest information, which could potentially be more accurate than what they and others contributing to the consensus had predicted earlier.
Thus, a positive or negative Earnings ESP reading theoretically indicates the likely deviation of the actual earnings from the consensus estimate. However, the model's predictive power is significant for positive ESP readings only.
A positive Earnings ESP is a strong predictor of an earnings beat, particularly when combined with a Zacks Rank #1 (Strong Buy), 2 (Buy) or 3 (Hold). Our research shows that stocks with this combination produce a positive surprise nearly 70% of the time, and a solid Zacks Rank actually increases the predictive power of Earnings ESP.
Please note that a negative Earnings ESP reading is not indicative of an earnings miss. Our research shows that it is difficult to predict an earnings beat with any degree of confidence for stocks with negative Earnings ESP readings and/or Zacks Rank of 4 (Sell) or 5 (Strong Sell).
How Have the Numbers Shaped Up for Nektar?For Nektar, the Most Accurate Estimate is lower than the Zacks Consensus Estimate, suggesting that analysts have recently become bearish on the company's earnings prospects. This has resulted in an Earnings ESP of -48.28%.
On the other hand, the stock currently carries a Zacks Rank of #2.
So, this combination makes it difficult to conclusively predict that Nektar will beat the consensus EPS estimate.
Does Earnings Surprise History Hold Any Clue?While calculating estimates for a company's future earnings, analysts often consider to what extent it has been able to match past consensus estimates. So, it's worth taking a look at the surprise history for gauging its influence on the upcoming number.
For the last reported quarter, it was expected that Nektar would post a loss of$2.85 per share when it actually produced a loss of -$1.85, delivering a surprise of +35.09%.
Over the last four quarters, the company has beaten consensus EPS estimates two times.
Bottom LineAn earnings beat or miss may not be the sole basis for a stock moving higher or lower. Many stocks end up losing ground despite an earnings beat due to other factors that disappoint investors. Similarly, unforeseen catalysts help a number of stocks gain despite an earnings miss.
That said, betting on stocks that are expected to beat earnings expectations does increase the odds of success. This is why it's worth checking a company's Earnings ESP and Zacks Rank ahead of its quarterly release. Make sure to utilize our Earnings ESP Filter to uncover the best stocks to buy or sell before they've reported.
Nektar doesn't appear a compelling earnings-beat candidate. However, investors should pay attention to other factors too for betting on this stock or staying away from it ahead of its earnings release.
Expected Results of an Industry PlayerAmong the stocks in the Zacks Medical - Drugs industry, electroCore, Inc. (ECOR - Free Report) , is soon expected to post loss of $0.35 per share for the quarter ended December 2025. This estimate indicates a year-over-year change of +12.5%. This quarter's revenue is expected to be $9.26 million, up 31.4% from the year-ago quarter.
Over the last 30 days, the consensus EPS estimate for electroCore has been revised 17% up to the current level. Nevertheless, the company now has an Earnings ESP of -13.04%, reflecting a lower Most Accurate Estimate.
This Earnings ESP, combined with its Zacks Rank #4 (Sell), makes it difficult to conclusively predict that electroCore will beat the consensus EPS estimate. Over the last four quarters, the company surpassed EPS estimates just once.
Stay on top of upcoming earnings announcements with the Zacks Earnings Calendar.
2026-03-05 16:056d ago
2026-03-05 11:016d ago
Lifetime Brands (LCUT) Expected to Beat Earnings Estimates: Should You Buy?
Wall Street expects a year-over-year decline in earnings on lower revenues when Lifetime Brands (LCUT - Free Report) reports results for the quarter ended December 2025. While this widely-known consensus outlook is important in gauging the company's earnings picture, a powerful factor that could impact its near-term stock price is how the actual results compare to these estimates.
The stock might move higher if these key numbers top expectations in the upcoming earnings report, which is expected to be released on March 12. On the other hand, if they miss, the stock may move lower.
While management's discussion of business conditions on the earnings call will mostly determine the sustainability of the immediate price change and future earnings expectations, it's worth having a handicapping insight into the odds of a positive EPS surprise.
Zacks Consensus EstimateThis kitchen products company is expected to post quarterly earnings of $0.29 per share in its upcoming report, which represents a year-over-year change of -47.3%.
Revenues are expected to be $202.44 million, down 5.9% from the year-ago quarter.
Estimate Revisions TrendThe consensus EPS estimate for the quarter has been revised 2.94% higher over the last 30 days to the current level. This is essentially a reflection of how the covering analysts have collectively reassessed their initial estimates over this period.
Investors should keep in mind that an aggregate change may not always reflect the direction of estimate revisions by each of the covering analysts.
Price, Consensus and EPS Surprise
Earnings WhisperEstimate revisions ahead of a company's earnings release offer clues to the business conditions for the period whose results are coming out. This insight is at the core of our proprietary surprise prediction model -- the Zacks Earnings ESP (Expected Surprise Prediction).
The Zacks Earnings ESP compares the Most Accurate Estimate to the Zacks Consensus Estimate for the quarter; the Most Accurate Estimate is a more recent version of the Zacks Consensus EPS estimate. The idea here is that analysts revising their estimates right before an earnings release have the latest information, which could potentially be more accurate than what they and others contributing to the consensus had predicted earlier.
Thus, a positive or negative Earnings ESP reading theoretically indicates the likely deviation of the actual earnings from the consensus estimate. However, the model's predictive power is significant for positive ESP readings only.
A positive Earnings ESP is a strong predictor of an earnings beat, particularly when combined with a Zacks Rank #1 (Strong Buy), 2 (Buy) or 3 (Hold). Our research shows that stocks with this combination produce a positive surprise nearly 70% of the time, and a solid Zacks Rank actually increases the predictive power of Earnings ESP.
Please note that a negative Earnings ESP reading is not indicative of an earnings miss. Our research shows that it is difficult to predict an earnings beat with any degree of confidence for stocks with negative Earnings ESP readings and/or Zacks Rank of 4 (Sell) or 5 (Strong Sell).
How Have the Numbers Shaped Up for Lifetime Brands?For Lifetime Brands, the Most Accurate Estimate is higher than the Zacks Consensus Estimate, suggesting that analysts have recently become bullish on the company's earnings prospects. This has resulted in an Earnings ESP of +37.93%.
On the other hand, the stock currently carries a Zacks Rank of #3.
So, this combination indicates that Lifetime Brands will most likely beat the consensus EPS estimate.
Does Earnings Surprise History Hold Any Clue?While calculating estimates for a company's future earnings, analysts often consider to what extent it has been able to match past consensus estimates. So, it's worth taking a look at the surprise history for gauging its influence on the upcoming number.
For the last reported quarter, it was expected that Lifetime Brands would post earnings of $0.1 per share when it actually produced earnings of $0.11, delivering a surprise of +10.00%.
Over the last four quarters, the company has beaten consensus EPS estimates two times.
Bottom LineAn earnings beat or miss may not be the sole basis for a stock moving higher or lower. Many stocks end up losing ground despite an earnings beat due to other factors that disappoint investors. Similarly, unforeseen catalysts help a number of stocks gain despite an earnings miss.
That said, betting on stocks that are expected to beat earnings expectations does increase the odds of success. This is why it's worth checking a company's Earnings ESP and Zacks Rank ahead of its quarterly release. Make sure to utilize our Earnings ESP Filter to uncover the best stocks to buy or sell before they've reported.
Lifetime Brands appears a compelling earnings-beat candidate. However, investors should pay attention to other factors too for betting on this stock or staying away from it ahead of its earnings release.
Stay on top of upcoming earnings announcements with the Zacks Earnings Calendar.
2026-03-05 16:056d ago
2026-03-05 11:016d ago
Wheaton Precious Metals Corp. (WPM) Reports Next Week: Wall Street Expects Earnings Growth
Wheaton Precious Metals Corp. (WPM - Free Report) is expected to deliver a year-over-year increase in earnings on higher revenues when it reports results for the quarter ended December 2025. This widely-known consensus outlook gives a good sense of the company's earnings picture, but how the actual results compare to these estimates is a powerful factor that could impact its near-term stock price.
The earnings report, which is expected to be released on March 12, might help the stock move higher if these key numbers are better than expectations. On the other hand, if they miss, the stock may move lower.
While the sustainability of the immediate price change and future earnings expectations will mostly depend on management's discussion of business conditions on the earnings call, it's worth handicapping the probability of a positive EPS surprise.
Zacks Consensus EstimateThis company is expected to post quarterly earnings of $0.92 per share in its upcoming report, which represents a year-over-year change of +109.1%.
Revenues are expected to be $648.96 million, up 70.6% from the year-ago quarter.
Estimate Revisions TrendThe consensus EPS estimate for the quarter has been revised 8.38% higher over the last 30 days to the current level. This is essentially a reflection of how the covering analysts have collectively reassessed their initial estimates over this period.
Investors should keep in mind that an aggregate change may not always reflect the direction of estimate revisions by each of the covering analysts.
Price, Consensus and EPS Surprise
Earnings WhisperEstimate revisions ahead of a company's earnings release offer clues to the business conditions for the period whose results are coming out. This insight is at the core of our proprietary surprise prediction model -- the Zacks Earnings ESP (Expected Surprise Prediction).
The Zacks Earnings ESP compares the Most Accurate Estimate to the Zacks Consensus Estimate for the quarter; the Most Accurate Estimate is a more recent version of the Zacks Consensus EPS estimate. The idea here is that analysts revising their estimates right before an earnings release have the latest information, which could potentially be more accurate than what they and others contributing to the consensus had predicted earlier.
Thus, a positive or negative Earnings ESP reading theoretically indicates the likely deviation of the actual earnings from the consensus estimate. However, the model's predictive power is significant for positive ESP readings only.
A positive Earnings ESP is a strong predictor of an earnings beat, particularly when combined with a Zacks Rank #1 (Strong Buy), 2 (Buy) or 3 (Hold). Our research shows that stocks with this combination produce a positive surprise nearly 70% of the time, and a solid Zacks Rank actually increases the predictive power of Earnings ESP.
Please note that a negative Earnings ESP reading is not indicative of an earnings miss. Our research shows that it is difficult to predict an earnings beat with any degree of confidence for stocks with negative Earnings ESP readings and/or Zacks Rank of 4 (Sell) or 5 (Strong Sell).
How Have the Numbers Shaped Up for Wheaton Precious Metals?For Wheaton Precious Metals, the Most Accurate Estimate is higher than the Zacks Consensus Estimate, suggesting that analysts have recently become bullish on the company's earnings prospects. This has resulted in an Earnings ESP of +16.35%.
On the other hand, the stock currently carries a Zacks Rank of #1.
So, this combination indicates that Wheaton Precious Metals will most likely beat the consensus EPS estimate.
Does Earnings Surprise History Hold Any Clue?Analysts often consider to what extent a company has been able to match consensus estimates in the past while calculating their estimates for its future earnings. So, it's worth taking a look at the surprise history for gauging its influence on the upcoming number.
For the last reported quarter, it was expected that Wheaton Precious Metals would post earnings of $0.59 per share when it actually produced earnings of $0.62, delivering a surprise of +5.08%.
Over the last four quarters, the company has beaten consensus EPS estimates three times.
Bottom LineAn earnings beat or miss may not be the sole basis for a stock moving higher or lower. Many stocks end up losing ground despite an earnings beat due to other factors that disappoint investors. Similarly, unforeseen catalysts help a number of stocks gain despite an earnings miss.
That said, betting on stocks that are expected to beat earnings expectations does increase the odds of success. This is why it's worth checking a company's Earnings ESP and Zacks Rank ahead of its quarterly release. Make sure to utilize our Earnings ESP Filter to uncover the best stocks to buy or sell before they've reported.
Wheaton Precious Metals appears a compelling earnings-beat candidate. However, investors should pay attention to other factors too for betting on this stock or staying away from it ahead of its earnings release.
Stay on top of upcoming earnings announcements with the Zacks Earnings Calendar.
2026-03-05 16:056d ago
2026-03-05 11:016d ago
Ballard Power Systems (BLDP) May Report Negative Earnings: Know the Trend Ahead of Next Week's Release
The market expects Ballard Power Systems (BLDP - Free Report) to deliver a year-over-year increase in earnings on higher revenues when it reports results for the quarter ended December 2025. This widely-known consensus outlook is important in assessing the company's earnings picture, but a powerful factor that might influence its near-term stock price is how the actual results compare to these estimates.
The earnings report, which is expected to be released on March 12, might help the stock move higher if these key numbers are better than expectations. On the other hand, if they miss, the stock may move lower.
While management's discussion of business conditions on the earnings call will mostly determine the sustainability of the immediate price change and future earnings expectations, it's worth having a handicapping insight into the odds of a positive EPS surprise.
Zacks Consensus EstimateThis fuel cell technology company is expected to post quarterly loss of $0.07 per share in its upcoming report, which represents a year-over-year change of +50%.
Revenues are expected to be $29.83 million, up 21.7% from the year-ago quarter.
Estimate Revisions TrendThe consensus EPS estimate for the quarter has remained unchanged over the last 30 days. This is essentially a reflection of how the covering analysts have collectively reassessed their initial estimates over this period.
Investors should keep in mind that the direction of estimate revisions by each of the covering analysts may not always get reflected in the aggregate change.
Price, Consensus and EPS Surprise
Earnings WhisperEstimate revisions ahead of a company's earnings release offer clues to the business conditions for the period whose results are coming out. Our proprietary surprise prediction model -- the Zacks Earnings ESP (Expected Surprise Prediction) -- has this insight at its core.
The Zacks Earnings ESP compares the Most Accurate Estimate to the Zacks Consensus Estimate for the quarter; the Most Accurate Estimate is a more recent version of the Zacks Consensus EPS estimate. The idea here is that analysts revising their estimates right before an earnings release have the latest information, which could potentially be more accurate than what they and others contributing to the consensus had predicted earlier.
Thus, a positive or negative Earnings ESP reading theoretically indicates the likely deviation of the actual earnings from the consensus estimate. However, the model's predictive power is significant for positive ESP readings only.
A positive Earnings ESP is a strong predictor of an earnings beat, particularly when combined with a Zacks Rank #1 (Strong Buy), 2 (Buy) or 3 (Hold). Our research shows that stocks with this combination produce a positive surprise nearly 70% of the time, and a solid Zacks Rank actually increases the predictive power of Earnings ESP.
Please note that a negative Earnings ESP reading is not indicative of an earnings miss. Our research shows that it is difficult to predict an earnings beat with any degree of confidence for stocks with negative Earnings ESP readings and/or Zacks Rank of 4 (Sell) or 5 (Strong Sell).
How Have the Numbers Shaped Up for Ballard?For Ballard, the Most Accurate Estimate is lower than the Zacks Consensus Estimate, suggesting that analysts have recently become bearish on the company's earnings prospects. This has resulted in an Earnings ESP of -5.00%.
On the other hand, the stock currently carries a Zacks Rank of #3.
So, this combination makes it difficult to conclusively predict that Ballard will beat the consensus EPS estimate.
Does Earnings Surprise History Hold Any Clue?While calculating estimates for a company's future earnings, analysts often consider to what extent it has been able to match past consensus estimates. So, it's worth taking a look at the surprise history for gauging its influence on the upcoming number.
For the last reported quarter, it was expected that Ballard would post a loss of$0.11 per share when it actually produced a loss of -$0.09, delivering a surprise of +18.18%.
Over the last four quarters, the company has beaten consensus EPS estimates three times.
Bottom LineAn earnings beat or miss may not be the sole basis for a stock moving higher or lower. Many stocks end up losing ground despite an earnings beat due to other factors that disappoint investors. Similarly, unforeseen catalysts help a number of stocks gain despite an earnings miss.
That said, betting on stocks that are expected to beat earnings expectations does increase the odds of success. This is why it's worth checking a company's Earnings ESP and Zacks Rank ahead of its quarterly release. Make sure to utilize our Earnings ESP Filter to uncover the best stocks to buy or sell before they've reported.
Ballard doesn't appear a compelling earnings-beat candidate. However, investors should pay attention to other factors too for betting on this stock or staying away from it ahead of its earnings release.
Stay on top of upcoming earnings announcements with the Zacks Earnings Calendar.
2026-03-05 16:056d ago
2026-03-05 11:016d ago
Adobe Systems (ADBE) Earnings Expected to Grow: What to Know Ahead of Next Week's Release
The market expects Adobe Systems (ADBE - Free Report) to deliver a year-over-year increase in earnings on higher revenues when it reports results for the quarter ended February 2026. This widely-known consensus outlook is important in assessing the company's earnings picture, but a powerful factor that might influence its near-term stock price is how the actual results compare to these estimates.
The earnings report, which is expected to be released on March 12, might help the stock move higher if these key numbers are better than expectations. On the other hand, if they miss, the stock may move lower.
While management's discussion of business conditions on the earnings call will mostly determine the sustainability of the immediate price change and future earnings expectations, it's worth having a handicapping insight into the odds of a positive EPS surprise.
Zacks Consensus EstimateThis software maker is expected to post quarterly earnings of $5.88 per share in its upcoming report, which represents a year-over-year change of +15.8%.
Revenues are expected to be $6.28 billion, up 9.9% from the year-ago quarter.
Estimate Revisions TrendThe consensus EPS estimate for the quarter has remained unchanged over the last 30 days. This is essentially a reflection of how the covering analysts have collectively reassessed their initial estimates over this period.
Investors should keep in mind that the direction of estimate revisions by each of the covering analysts may not always get reflected in the aggregate change.
Price, Consensus and EPS Surprise
Earnings WhisperEstimate revisions ahead of a company's earnings release offer clues to the business conditions for the period whose results are coming out. Our proprietary surprise prediction model -- the Zacks Earnings ESP (Expected Surprise Prediction) -- has this insight at its core.
The Zacks Earnings ESP compares the Most Accurate Estimate to the Zacks Consensus Estimate for the quarter; the Most Accurate Estimate is a more recent version of the Zacks Consensus EPS estimate. The idea here is that analysts revising their estimates right before an earnings release have the latest information, which could potentially be more accurate than what they and others contributing to the consensus had predicted earlier.
Thus, a positive or negative Earnings ESP reading theoretically indicates the likely deviation of the actual earnings from the consensus estimate. However, the model's predictive power is significant for positive ESP readings only.
A positive Earnings ESP is a strong predictor of an earnings beat, particularly when combined with a Zacks Rank #1 (Strong Buy), 2 (Buy) or 3 (Hold). Our research shows that stocks with this combination produce a positive surprise nearly 70% of the time, and a solid Zacks Rank actually increases the predictive power of Earnings ESP.
Please note that a negative Earnings ESP reading is not indicative of an earnings miss. Our research shows that it is difficult to predict an earnings beat with any degree of confidence for stocks with negative Earnings ESP readings and/or Zacks Rank of 4 (Sell) or 5 (Strong Sell).
How Have the Numbers Shaped Up for Adobe?For Adobe, the Most Accurate Estimate is higher than the Zacks Consensus Estimate, suggesting that analysts have recently become bullish on the company's earnings prospects. This has resulted in an Earnings ESP of +0.04%.
On the other hand, the stock currently carries a Zacks Rank of #4.
So, this combination makes it difficult to conclusively predict that Adobe will beat the consensus EPS estimate.
Does Earnings Surprise History Hold Any Clue?Analysts often consider to what extent a company has been able to match consensus estimates in the past while calculating their estimates for its future earnings. So, it's worth taking a look at the surprise history for gauging its influence on the upcoming number.
For the last reported quarter, it was expected that Adobe would post earnings of $5.39 per share when it actually produced earnings of $5.50, delivering a surprise of +2.04%.
Over the last four quarters, the company has beaten consensus EPS estimates four times.
Bottom LineAn earnings beat or miss may not be the sole basis for a stock moving higher or lower. Many stocks end up losing ground despite an earnings beat due to other factors that disappoint investors. Similarly, unforeseen catalysts help a number of stocks gain despite an earnings miss.
That said, betting on stocks that are expected to beat earnings expectations does increase the odds of success. This is why it's worth checking a company's Earnings ESP and Zacks Rank ahead of its quarterly release. Make sure to utilize our Earnings ESP Filter to uncover the best stocks to buy or sell before they've reported.
Adobe doesn't appear a compelling earnings-beat candidate. However, investors should pay attention to other factors too for betting on this stock or staying away from it ahead of its earnings release.
Expected Results of an Industry PlayerAmong the stocks in the Zacks Computer - Software industry, Oracle (ORCL - Free Report) , is soon expected to post earnings of $1.7 per share for the quarter ended February 2026. This estimate indicates a year-over-year change of +15.7%. This quarter's revenue is expected to be $16.89 billion, up 19.5% from the year-ago quarter.
The consensus EPS estimate for Oracle has remained unchanged over the last 30 days. However, a higher Most Accurate Estimate has resulted in an Earnings ESP of +1.12%.
This Earnings ESP, combined with its Zacks Rank #3 (Hold), suggests that Oracle will most likely beat the consensus EPS estimate. Over the last four quarters, the company surpassed consensus EPS estimates two times.
Stay on top of upcoming earnings announcements with the Zacks Earnings Calendar.
2026-03-05 16:056d ago
2026-03-05 11:016d ago
Dollar General (DG) Expected to Beat Earnings Estimates: Can the Stock Move Higher?
The market expects Dollar General (DG - Free Report) to deliver a year-over-year decline in earnings on higher revenues when it reports results for the quarter ended January 2026. This widely-known consensus outlook is important in assessing the company's earnings picture, but a powerful factor that might influence its near-term stock price is how the actual results compare to these estimates.
The earnings report, which is expected to be released on March 12, might help the stock move higher if these key numbers are better than expectations. On the other hand, if they miss, the stock may move lower.
While management's discussion of business conditions on the earnings call will mostly determine the sustainability of the immediate price change and future earnings expectations, it's worth having a handicapping insight into the odds of a positive EPS surprise.
Zacks Consensus EstimateThis discount retailer is expected to post quarterly earnings of $1.61 per share in its upcoming report, which represents a year-over-year change of -4.2%.
Revenues are expected to be $10.78 billion, up 4.7% from the year-ago quarter.
Estimate Revisions TrendThe consensus EPS estimate for the quarter has been revised 0.21% higher over the last 30 days to the current level. This is essentially a reflection of how the covering analysts have collectively reassessed their initial estimates over this period.
Investors should keep in mind that the direction of estimate revisions by each of the covering analysts may not always get reflected in the aggregate change.
Price, Consensus and EPS Surprise
Earnings WhisperEstimate revisions ahead of a company's earnings release offer clues to the business conditions for the period whose results are coming out. This insight is at the core of our proprietary surprise prediction model -- the Zacks Earnings ESP (Expected Surprise Prediction).
The Zacks Earnings ESP compares the Most Accurate Estimate to the Zacks Consensus Estimate for the quarter; the Most Accurate Estimate is a more recent version of the Zacks Consensus EPS estimate. The idea here is that analysts revising their estimates right before an earnings release have the latest information, which could potentially be more accurate than what they and others contributing to the consensus had predicted earlier.
Thus, a positive or negative Earnings ESP reading theoretically indicates the likely deviation of the actual earnings from the consensus estimate. However, the model's predictive power is significant for positive ESP readings only.
A positive Earnings ESP is a strong predictor of an earnings beat, particularly when combined with a Zacks Rank #1 (Strong Buy), 2 (Buy) or 3 (Hold). Our research shows that stocks with this combination produce a positive surprise nearly 70% of the time, and a solid Zacks Rank actually increases the predictive power of Earnings ESP.
Please note that a negative Earnings ESP reading is not indicative of an earnings miss. Our research shows that it is difficult to predict an earnings beat with any degree of confidence for stocks with negative Earnings ESP readings and/or Zacks Rank of 4 (Sell) or 5 (Strong Sell).
How Have the Numbers Shaped Up for Dollar General?For Dollar General, the Most Accurate Estimate is higher than the Zacks Consensus Estimate, suggesting that analysts have recently become bullish on the company's earnings prospects. This has resulted in an Earnings ESP of +5.38%.
On the other hand, the stock currently carries a Zacks Rank of #3.
So, this combination indicates that Dollar General will most likely beat the consensus EPS estimate.
Does Earnings Surprise History Hold Any Clue?Analysts often consider to what extent a company has been able to match consensus estimates in the past while calculating their estimates for its future earnings. So, it's worth taking a look at the surprise history for gauging its influence on the upcoming number.
For the last reported quarter, it was expected that Dollar General would post earnings of $0.92 per share when it actually produced earnings of $1.28, delivering a surprise of +39.13%.
Over the last four quarters, the company has beaten consensus EPS estimates four times.
Bottom LineAn earnings beat or miss may not be the sole basis for a stock moving higher or lower. Many stocks end up losing ground despite an earnings beat due to other factors that disappoint investors. Similarly, unforeseen catalysts help a number of stocks gain despite an earnings miss.
That said, betting on stocks that are expected to beat earnings expectations does increase the odds of success. This is why it's worth checking a company's Earnings ESP and Zacks Rank ahead of its quarterly release. Make sure to utilize our Earnings ESP Filter to uncover the best stocks to buy or sell before they've reported.
Dollar General appears a compelling earnings-beat candidate. However, investors should pay attention to other factors too for betting on this stock or staying away from it ahead of its earnings release.
Stay on top of upcoming earnings announcements with the Zacks Earnings Calendar.
The market expects Mach Natural Resources LP (MNR - Free Report) to deliver a year-over-year decline in earnings on higher revenues when it reports results for the quarter ended December 2025. This widely-known consensus outlook is important in assessing the company's earnings picture, but a powerful factor that might influence its near-term stock price is how the actual results compare to these estimates.
The earnings report, which is expected to be released on March 12, might help the stock move higher if these key numbers are better than expectations. On the other hand, if they miss, the stock may move lower.
While management's discussion of business conditions on the earnings call will mostly determine the sustainability of the immediate price change and future earnings expectations, it's worth having a handicapping insight into the odds of a positive EPS surprise.
Zacks Consensus EstimateThis company is expected to post quarterly earnings of $0.26 per share in its upcoming report, which represents a year-over-year change of -58.1%.
Revenues are expected to be $361.93 million, up 54.1% from the year-ago quarter.
Estimate Revisions TrendThe consensus EPS estimate for the quarter has been revised 13.48% higher over the last 30 days to the current level. This is essentially a reflection of how the covering analysts have collectively reassessed their initial estimates over this period.
Investors should keep in mind that an aggregate change may not always reflect the direction of estimate revisions by each of the covering analysts.
Price, Consensus and EPS Surprise
Earnings WhisperEstimate revisions ahead of a company's earnings release offer clues to the business conditions for the period whose results are coming out. This insight is at the core of our proprietary surprise prediction model -- the Zacks Earnings ESP (Expected Surprise Prediction).
The Zacks Earnings ESP compares the Most Accurate Estimate to the Zacks Consensus Estimate for the quarter; the Most Accurate Estimate is a more recent version of the Zacks Consensus EPS estimate. The idea here is that analysts revising their estimates right before an earnings release have the latest information, which could potentially be more accurate than what they and others contributing to the consensus had predicted earlier.
Thus, a positive or negative Earnings ESP reading theoretically indicates the likely deviation of the actual earnings from the consensus estimate. However, the model's predictive power is significant for positive ESP readings only.
A positive Earnings ESP is a strong predictor of an earnings beat, particularly when combined with a Zacks Rank #1 (Strong Buy), 2 (Buy) or 3 (Hold). Our research shows that stocks with this combination produce a positive surprise nearly 70% of the time, and a solid Zacks Rank actually increases the predictive power of Earnings ESP.
Please note that a negative Earnings ESP reading is not indicative of an earnings miss. Our research shows that it is difficult to predict an earnings beat with any degree of confidence for stocks with negative Earnings ESP readings and/or Zacks Rank of 4 (Sell) or 5 (Strong Sell).
How Have the Numbers Shaped Up for Mach Natural Resources LP?For Mach Natural Resources LP, the Most Accurate Estimate is higher than the Zacks Consensus Estimate, suggesting that analysts have recently become bullish on the company's earnings prospects. This has resulted in an Earnings ESP of +35.92%.
On the other hand, the stock currently carries a Zacks Rank of #5.
So, this combination makes it difficult to conclusively predict that Mach Natural Resources LP will beat the consensus EPS estimate.
Does Earnings Surprise History Hold Any Clue?Analysts often consider to what extent a company has been able to match consensus estimates in the past while calculating their estimates for its future earnings. So, it's worth taking a look at the surprise history for gauging its influence on the upcoming number.
For the last reported quarter, it was expected that Mach Natural Resources LP would post earnings of $0.34 per share when it actually produced earnings of $0.44, delivering a surprise of +29.41%.
Over the last four quarters, the company has beaten consensus EPS estimates three times.
Bottom LineAn earnings beat or miss may not be the sole basis for a stock moving higher or lower. Many stocks end up losing ground despite an earnings beat due to other factors that disappoint investors. Similarly, unforeseen catalysts help a number of stocks gain despite an earnings miss.
That said, betting on stocks that are expected to beat earnings expectations does increase the odds of success. This is why it's worth checking a company's Earnings ESP and Zacks Rank ahead of its quarterly release. Make sure to utilize our Earnings ESP Filter to uncover the best stocks to buy or sell before they've reported.
Mach Natural Resources LP doesn't appear a compelling earnings-beat candidate. However, investors should pay attention to other factors too for betting on this stock or staying away from it ahead of its earnings release.
Stay on top of upcoming earnings announcements with the Zacks Earnings Calendar.
2026-03-05 16:056d ago
2026-03-05 11:016d ago
Is the Options Market Predicting a Spike in Axcelis Technologies Stock?
Investors in Axcelis Technologies, Inc. (ACLS - Free Report) need to pay close attention to the stock based on moves in the options market lately. That is because the Mar 20, 2026 $50.00 Call had some of the highest implied volatility of all equity options today.
What is Implied Volatility?Implied volatility shows how much movement the market is expecting in the future. Options with high levels of implied volatility suggest that investors in the underlying stocks are expecting a big move in one direction or the other. It could also mean there is an event coming up soon that may cause a big rally or a huge sell off. However, implied volatility is only one piece of the puzzle when putting together an options trading strategy.
What do the Analysts Think?Clearly, options traders are pricing in a big move for Axcelis Technologies share, but what is the fundamental picture for the company? Currently, Axcelis Technologies is a Zacks Rank #5 (Strong Sell) in the Electronics - Manufacturing Machinery Industry that ranks in the Top 10% of our Zacks Industry Rank. Over the last 60 days, no analyst has increased his estimate for the current quarter, while two have revised their estimates downwards. The net effect has taken our Zacks Consensus Estimate for the current quarter to move from 89 cents per share to 71 cents per share in the same time period.
Given the way analysts feel about Axcelis Technologies right now, this huge implied volatility could mean there’s a trade developing. Often times, options traders look for options with high levels of implied volatility to sell premium. This is a strategy many seasoned traders use because it captures decay. At expiration, the hope for these traders is that the underlying stock does not move as much as originally expected.
2026-03-05 16:056d ago
2026-03-05 11:016d ago
Earnings Preview: KinderCare Learning Companies, Inc. (KLC) Q4 Earnings Expected to Decline
Wall Street expects a year-over-year decline in earnings on higher revenues when KinderCare Learning Companies, Inc. (KLC - Free Report) reports results for the quarter ended December 2025. While this widely-known consensus outlook is important in gauging the company's earnings picture, a powerful factor that could impact its near-term stock price is how the actual results compare to these estimates.
The stock might move higher if these key numbers top expectations in the upcoming earnings report, which is expected to be released on March 12. On the other hand, if they miss, the stock may move lower.
While management's discussion of business conditions on the earnings call will mostly determine the sustainability of the immediate price change and future earnings expectations, it's worth having a handicapping insight into the odds of a positive EPS surprise.
Zacks Consensus EstimateThis company is expected to post quarterly earnings of $0.08 per share in its upcoming report, which represents a year-over-year change of -11.1%.
Revenues are expected to be $686.32 million, up 6.1% from the year-ago quarter.
Estimate Revisions TrendThe consensus EPS estimate for the quarter has remained unchanged over the last 30 days. This is essentially a reflection of how the covering analysts have collectively reassessed their initial estimates over this period.
Investors should keep in mind that an aggregate change may not always reflect the direction of estimate revisions by each of the covering analysts.
Price, Consensus and EPS Surprise
Earnings WhisperEstimate revisions ahead of a company's earnings release offer clues to the business conditions for the period whose results are coming out. This insight is at the core of our proprietary surprise prediction model -- the Zacks Earnings ESP (Expected Surprise Prediction).
The Zacks Earnings ESP compares the Most Accurate Estimate to the Zacks Consensus Estimate for the quarter; the Most Accurate Estimate is a more recent version of the Zacks Consensus EPS estimate. The idea here is that analysts revising their estimates right before an earnings release have the latest information, which could potentially be more accurate than what they and others contributing to the consensus had predicted earlier.
Thus, a positive or negative Earnings ESP reading theoretically indicates the likely deviation of the actual earnings from the consensus estimate. However, the model's predictive power is significant for positive ESP readings only.
A positive Earnings ESP is a strong predictor of an earnings beat, particularly when combined with a Zacks Rank #1 (Strong Buy), 2 (Buy) or 3 (Hold). Our research shows that stocks with this combination produce a positive surprise nearly 70% of the time, and a solid Zacks Rank actually increases the predictive power of Earnings ESP.
Please note that a negative Earnings ESP reading is not indicative of an earnings miss. Our research shows that it is difficult to predict an earnings beat with any degree of confidence for stocks with negative Earnings ESP readings and/or Zacks Rank of 4 (Sell) or 5 (Strong Sell).
How Have the Numbers Shaped Up for KinderCare Learning Companies, Inc.?For KinderCare Learning Companies, Inc., the Most Accurate Estimate is lower than the Zacks Consensus Estimate, suggesting that analysts have recently become bearish on the company's earnings prospects. This has resulted in an Earnings ESP of -4.00%.
On the other hand, the stock currently carries a Zacks Rank of #4.
So, this combination makes it difficult to conclusively predict that KinderCare Learning Companies, Inc. will beat the consensus EPS estimate.
Does Earnings Surprise History Hold Any Clue?Analysts often consider to what extent a company has been able to match consensus estimates in the past while calculating their estimates for its future earnings. So, it's worth taking a look at the surprise history for gauging its influence on the upcoming number.
For the last reported quarter, it was expected that KinderCare Learning Companies, Inc. would post earnings of $0.12 per share when it actually produced earnings of $0.13, delivering a surprise of +8.33%.
Over the last four quarters, the company has beaten consensus EPS estimates three times.
Bottom LineAn earnings beat or miss may not be the sole basis for a stock moving higher or lower. Many stocks end up losing ground despite an earnings beat due to other factors that disappoint investors. Similarly, unforeseen catalysts help a number of stocks gain despite an earnings miss.
That said, betting on stocks that are expected to beat earnings expectations does increase the odds of success. This is why it's worth checking a company's Earnings ESP and Zacks Rank ahead of its quarterly release. Make sure to utilize our Earnings ESP Filter to uncover the best stocks to buy or sell before they've reported.
KinderCare Learning Companies, Inc. doesn't appear a compelling earnings-beat candidate. However, investors should pay attention to other factors too for betting on this stock or staying away from it ahead of its earnings release.
Stay on top of upcoming earnings announcements with the Zacks Earnings Calendar.
2026-03-05 15:046d ago
2026-03-05 10:016d ago
Investors Heavily Search lululemon athletica inc. (LULU): Here is What You Need to Know
Lululemon (LULU - Free Report) has recently been on Zacks.com's list of the most searched stocks. Therefore, you might want to consider some of the key factors that could influence the stock's performance in the near future.
Over the past month, shares of this athletic apparel maker have returned -2.7%, compared to the Zacks S&P 500 composite's -0.2% change. During this period, the Zacks Textile - Apparel industry, which Lululemon falls in, has gained 0.9%. The key question now is: What could be the stock's future direction?
While media releases or rumors about a substantial change in a company's business prospects usually make its stock 'trending' and lead to an immediate price change, there are always some fundamental facts that eventually dominate the buy-and-hold decision-making.
Earnings Estimate RevisionsRather than focusing on anything else, we at Zacks prioritize evaluating the change in a company's earnings projection. This is because we believe the fair value for its stock is determined by the present value of its future stream of earnings.
We essentially look at how sell-side analysts covering the stock are revising their earnings estimates to reflect the impact of the latest business trends. And if earnings estimates go up for a company, the fair value for its stock goes up. A higher fair value than the current market price drives investors' interest in buying the stock, leading to its price moving higher. This is why empirical research shows a strong correlation between trends in earnings estimate revisions and near-term stock price movements.
Lululemon is expected to post earnings of $4.74 per share for the current quarter, representing a year-over-year change of -22.8%. Over the last 30 days, the Zacks Consensus Estimate has changed +1.3%.
For the current fiscal year, the consensus earnings estimate of $13.06 points to a change of -10.8% from the prior year. Over the last 30 days, this estimate has changed +0.3%.
For the next fiscal year, the consensus earnings estimate of $12.8 indicates a change of -2% from what Lululemon is expected to report a year ago. Over the past month, the estimate has changed +0.3%.
Having a strong externally audited track record, our proprietary stock rating tool, the Zacks Rank, offers a more conclusive picture of a stock's price direction in the near term, since it effectively harnesses the power of earnings estimate revisions. Due to the size of the recent change in the consensus estimate, along with three other factors related to earnings estimates, Lululemon is rated Zacks Rank #3 (Hold).
The chart below shows the evolution of the company's forward 12-month consensus EPS estimate:
12 Month EPS
Projected Revenue GrowthWhile earnings growth is arguably the most superior indicator of a company's financial health, nothing happens as such if a business isn't able to grow its revenues. After all, it's nearly impossible for a company to increase its earnings for an extended period without increasing its revenues. So, it's important to know a company's potential revenue growth.
For Lululemon, the consensus sales estimate for the current quarter of $3.6 billion indicates a year-over-year change of -0.3%. For the current and next fiscal years, $11.09 billion and $11.62 billion estimates indicate +4.7% and +4.8% changes, respectively.
Last Reported Results and Surprise HistoryLululemon reported revenues of $2.57 billion in the last reported quarter, representing a year-over-year change of +7.1%. EPS of $2.59 for the same period compares with $2.87 a year ago.
Compared to the Zacks Consensus Estimate of $2.48 billion, the reported revenues represent a surprise of +3.4%. The EPS surprise was +16.67%.
The company beat consensus EPS estimates in each of the trailing four quarters. The company topped consensus revenue estimates three times over this period.
ValuationNo investment decision can be efficient without considering a stock's valuation. Whether a stock's current price rightly reflects the intrinsic value of the underlying business and the company's growth prospects is an essential determinant of its future price performance.
Comparing the current value of a company's valuation multiples, such as its price-to-earnings (P/E), price-to-sales (P/S), and price-to-cash flow (P/CF), to its own historical values helps ascertain whether its stock is fairly valued, overvalued, or undervalued, whereas comparing the company relative to its peers on these parameters gives a good sense of how reasonable its stock price is.
The Zacks Value Style Score (part of the Zacks Style Scores system), which pays close attention to both traditional and unconventional valuation metrics to grade stocks from A to F (an A is better than a B; a B is better than a C; and so on), is pretty helpful in identifying whether a stock is overvalued, rightly valued, or temporarily undervalued.
Lululemon is graded C on this front, indicating that it is trading at par with its peers. Click here to see the values of some of the valuation metrics that have driven this grade.
Bottom LineThe facts discussed here and much other information on Zacks.com might help determine whether or not it's worthwhile paying attention to the market buzz about Lululemon. However, its Zacks Rank #3 does suggest that it may perform in line with the broader market in the near term.
2026-03-05 15:046d ago
2026-03-05 10:016d ago
Here is What to Know Beyond Why First Solar, Inc. (FSLR) is a Trending Stock
First Solar (FSLR - Free Report) is one of the stocks most watched by Zacks.com visitors lately. So, it might be a good idea to review some of the factors that might affect the near-term performance of the stock.
Over the past month, shares of this largest U.S. solar company have returned -17.1%, compared to the Zacks S&P 500 composite's -0.2% change. During this period, the Zacks Solar industry, which First Solar falls in, has lost 16.9%. The key question now is: What could be the stock's future direction?
Although media reports or rumors about a significant change in a company's business prospects usually cause its stock to trend and lead to an immediate price change, there are always certain fundamental factors that ultimately drive the buy-and-hold decision.
Earnings Estimate RevisionsRather than focusing on anything else, we at Zacks prioritize evaluating the change in a company's earnings projection. This is because we believe the fair value for its stock is determined by the present value of its future stream of earnings.
We essentially look at how sell-side analysts covering the stock are revising their earnings estimates to reflect the impact of the latest business trends. And if earnings estimates go up for a company, the fair value for its stock goes up. A higher fair value than the current market price drives investors' interest in buying the stock, leading to its price moving higher. This is why empirical research shows a strong correlation between trends in earnings estimate revisions and near-term stock price movements.
For the current quarter, First Solar is expected to post earnings of $2.90 per share, indicating a change of +48.7% from the year-ago quarter. The Zacks Consensus Estimate has changed -31.7% over the last 30 days.
For the current fiscal year, the consensus earnings estimate of $18.57 points to a change of +30.7% from the prior year. Over the last 30 days, this estimate has changed -20.1%.
For the next fiscal year, the consensus earnings estimate of $25.23 indicates a change of +35.9% from what First Solar is expected to report a year ago. Over the past month, the estimate has changed -12.5%.
With an impressive externally audited track record, our proprietary stock rating tool -- the Zacks Rank -- is a more conclusive indicator of a stock's near-term price performance, as it effectively harnesses the power of earnings estimate revisions. The size of the recent change in the consensus estimate, along with three other factors related to earnings estimates, has resulted in a Zacks Rank #4 (Sell) for First Solar.
The chart below shows the evolution of the company's forward 12-month consensus EPS estimate:
12 Month EPS
Projected Revenue GrowthEven though a company's earnings growth is arguably the best indicator of its financial health, nothing much happens if it cannot raise its revenues. It's almost impossible for a company to grow its earnings without growing its revenue for long periods. Therefore, knowing a company's potential revenue growth is crucial.
For First Solar, the consensus sales estimate for the current quarter of $1.04 billion indicates a year-over-year change of +23.5%. For the current and next fiscal years, $5.1 billion and $6.18 billion estimates indicate -2.3% and +21.3% changes, respectively.
Last Reported Results and Surprise HistoryFirst Solar reported revenues of $1.68 billion in the last reported quarter, representing a year-over-year change of +11.1%. EPS of $4.84 for the same period compares with $3.65 a year ago.
Compared to the Zacks Consensus Estimate of $1.57 billion, the reported revenues represent a surprise of +7%. The EPS surprise was -7.28%.
Over the last four quarters, the company surpassed EPS estimates just once. The company topped consensus revenue estimates two times over this period.
ValuationNo investment decision can be efficient without considering a stock's valuation. Whether a stock's current price rightly reflects the intrinsic value of the underlying business and the company's growth prospects is an essential determinant of its future price performance.
While comparing the current values of a company's valuation multiples, such as price-to-earnings (P/E), price-to-sales (P/S), and price-to-cash flow (P/CF), with its own historical values helps determine whether its stock is fairly valued, overvalued, or undervalued, comparing the company relative to its peers on these parameters gives a good sense of the reasonability of the stock's price.
As part of the Zacks Style Scores system, the Zacks Value Style Score (which evaluates both traditional and unconventional valuation metrics) organizes stocks into five groups ranging from A to F (A is better than B; B is better than C; and so on), making it helpful in identifying whether a stock is overvalued, rightly valued, or temporarily undervalued.
First Solar is graded B on this front, indicating that it is trading at a discount to its peers. Click here to see the values of some of the valuation metrics that have driven this grade.
ConclusionThe facts discussed here and much other information on Zacks.com might help determine whether or not it's worthwhile paying attention to the market buzz about First Solar. However, its Zacks Rank #4 does suggest that it may underperform the broader market in the near term.
2026-03-05 15:046d ago
2026-03-05 10:016d ago
ASML Holding N.V. (ASML) Is a Trending Stock: Facts to Know Before Betting on It
ASML (ASML - Free Report) is one of the stocks most watched by Zacks.com visitors lately. So, it might be a good idea to review some of the factors that might affect the near-term performance of the stock.
Shares of this equipment supplier to semiconductor makers have returned +4.5% over the past month versus the Zacks S&P 500 composite's -0.2% change. The Zacks Semiconductor Equipment - Wafer Fabrication industry, to which ASML belongs, has gained 5% over this period. Now the key question is: Where could the stock be headed in the near term?
Although media reports or rumors about a significant change in a company's business prospects usually cause its stock to trend and lead to an immediate price change, there are always certain fundamental factors that ultimately drive the buy-and-hold decision.
Earnings Estimate RevisionsHere at Zacks, we prioritize appraising the change in the projection of a company's future earnings over anything else. That's because we believe the present value of its future stream of earnings is what determines the fair value for its stock.
Our analysis is essentially based on how sell-side analysts covering the stock are revising their earnings estimates to take the latest business trends into account. When earnings estimates for a company go up, the fair value for its stock goes up as well. And when a stock's fair value is higher than its current market price, investors tend to buy the stock, resulting in its price moving upward. Because of this, empirical studies indicate a strong correlation between trends in earnings estimate revisions and short-term stock price movements.
For the current quarter, ASML is expected to post earnings of $7.61 per share, indicating a change of +20.6% from the year-ago quarter. The Zacks Consensus Estimate remained unchanged over the last 30 days.
For the current fiscal year, the consensus earnings estimate of $33.67 points to a change of +20.5% from the prior year. Over the last 30 days, this estimate has changed +1.4%.
For the next fiscal year, the consensus earnings estimate of $41.6 indicates a change of +23.5% from what ASML is expected to report a year ago. Over the past month, the estimate has changed +1.8%.
Having a strong externally audited track record, our proprietary stock rating tool, the Zacks Rank, offers a more conclusive picture of a stock's price direction in the near term, since it effectively harnesses the power of earnings estimate revisions. Due to the size of the recent change in the consensus estimate, along with three other factors related to earnings estimates, ASML is rated Zacks Rank #3 (Hold).
The chart below shows the evolution of the company's forward 12-month consensus EPS estimate:
12 Month EPS
Projected Revenue GrowthWhile earnings growth is arguably the most superior indicator of a company's financial health, nothing happens as such if a business isn't able to grow its revenues. After all, it's nearly impossible for a company to increase its earnings for an extended period without increasing its revenues. So, it's important to know a company's potential revenue growth.
For ASML, the consensus sales estimate for the current quarter of $10.21 billion indicates a year-over-year change of +25.4%. For the current and next fiscal years, $43.44 billion and $51.82 billion estimates indicate +17.5% and +19.3% changes, respectively.
Last Reported Results and Surprise HistoryASML reported revenues of $11.31 billion in the last reported quarter, representing a year-over-year change of +14.5%. EPS of $8.55 for the same period compares with $7.3 a year ago.
Compared to the Zacks Consensus Estimate of $11.11 billion, the reported revenues represent a surprise of +1.79%. The EPS surprise was -5.42%.
Over the last four quarters, ASML surpassed consensus EPS estimates two times. The company topped consensus revenue estimates three times over this period.
ValuationWithout considering a stock's valuation, no investment decision can be efficient. In predicting a stock's future price performance, it's crucial to determine whether its current price correctly reflects the intrinsic value of the underlying business and the company's growth prospects.
Comparing the current value of a company's valuation multiples, such as its price-to-earnings (P/E), price-to-sales (P/S), and price-to-cash flow (P/CF), to its own historical values helps ascertain whether its stock is fairly valued, overvalued, or undervalued, whereas comparing the company relative to its peers on these parameters gives a good sense of how reasonable its stock price is.
As part of the Zacks Style Scores system, the Zacks Value Style Score (which evaluates both traditional and unconventional valuation metrics) organizes stocks into five groups ranging from A to F (A is better than B; B is better than C; and so on), making it helpful in identifying whether a stock is overvalued, rightly valued, or temporarily undervalued.
ASML is graded F on this front, indicating that it is trading at a premium to its peers. Click here to see the values of some of the valuation metrics that have driven this grade.
Bottom LineThe facts discussed here and much other information on Zacks.com might help determine whether or not it's worthwhile paying attention to the market buzz about ASML. However, its Zacks Rank #3 does suggest that it may perform in line with the broader market in the near term.